Season 4 of A View On is complete. One theme ran through it all: medicines are getting more complex, and so is making them. Host Martina Ribar Hestericova recaps the season and teases what's next. Listen now. www.youtube.com/watch?v=_pqyQtTRudE&list=PLh3u2rKfWyIch6h….
Lonza Group
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. More on Wikipedia
-
Lonza
@LonzaGroup
-
Lonza
@LonzaGroup
Lonza is at BioJapan in Yokohama and looking forward to seeing you there!
Schedule a meeting with us here www.lonza.com/contact or swing by our booth in the Swiss Pavilion D-34.
#lonza #biojapan -
Lonza
@LonzaGroup
We announced the expansion of our strategic collaboration with a leading US biopharma company, adding two biologics programs with the option for two more, reinforcing demand for our integrated solutions. Read more: www.lonza.com/news/2026-07-01-07-00
#lonza #cdmo #integratedbiologics -
Lonza
@LonzaGroup
We have announced plans to expand our payload-linker manufacturing capacity in Visp, including new commercial-scale production capabilities, further strengthening our integrated offering for ADCs.
www.lonza.com/news/2026-06-30-07-00
#lonza #cdmo #adcs #pharmaceuticalmanufacturing -
Lonza
@LonzaGroup
We have announced the launch of Xcite® AAV Stable Producer Cell Line technology to help gene therapy developers address scalability, cost of goods and process robustness as programs progress towards commercialization. Read more here: www.lonza.com/media-advisories/2026-05-12-14-00
#lonza #cdmo #aav -
Lonza
@LonzaGroup
In our Q1 qualitative update, Lonza reported a strong performance in line with expectations for Full-Year Outlook 2026, despite a changing geopolitical and macroeconomic environment. Read more here: www.lonza.com/news/2026-05-08-06-30
#lonza #growth #cdmo #pharmaceutical #biotechnology -
Lonza
@LonzaGroup
Today, we published our 2025 Annual and Sustainability Reports, providing a comprehensive overview of our performance and progress in executing the One Lonza strategy.
Explore the reports here: www.lonza.com/investor-relations/-/media/23FD04138D8A4F5B…
#lonza #cdmo #growth #sustainability #annualreport -
Lonza
@LonzaGroup
We have announced the launch of our Media Development Lab at our Singapore site, designed to optimize cell culture media development and facilitate a smooth transition to manufacturing. Read more here: www.lonza.com/media-advisories/2026-03-26-15-00
#lonza #cdmo #bioprocessing #cellculture -
Lonza
@LonzaGroup
We have extended our long-term commercial manufacturing agreement with Genetix Biotherapeutics. The agreement will focus on expanding manufacturing capacity at Lonza's Houston cell and gene therapy facility. Read more: www.lonza.com/news/2026-03-09-14-00
#lonza #cdmo #celltherapy -
Lonza
@LonzaGroup
Today, we signed an agreement to divest our Capsules & Health Ingredients business to Lone Star for an enterprise value of CHF 2.3 bn (USD 3 bn) at closing. The transaction completes our transformation into a pure-play CDMO. Read more: www.lonza.com/news/2026-03-06-18-05
-
Lonza
@LonzaGroup
We have announced the strengthening of our Advanced Synthesis offering to support ADC discovery, development, and manufacturing.
Read more: www.lonza.com/media-advisories/2026-02-19-09-00
#lonza #adcs #bioconjugates -
Lonza
@LonzaGroup
Today, we reported our financial results for Full-Year 2025, with sales of CHF 6.5 billion and a CORE EDITDA of CHF 2.1 billion resulting in a strong margin of 31.6%, ahead of our upgraded CDMO guidance.
Read more about our progress in FYR 2025 here: www.lonza.com/news/2026-01-28-06-30 -
Lonza reposted
U.S. Embassy Bern
@USEmbassyBern
Ambassador Callista L. Gingrich was pleased to meet @LonzaGroup CEO Dr. Wolfgang Wienand and Prof. Dr. Andreas Bohrer to learn about Lonza’s activities in the United States and Switzerland, including Lonza’s support for apprenticeship programs and plans for further expansion in the U.S. market. 🇺🇸🇨🇭 @SelectUSA
-
Lonza
@LonzaGroup
We have announced the acquisition of Redberry SAS, an innovative company specializing in rapid microbiology testing solutions using solid-phase cytometry technology. The transaction is expected to close in Q4 2025, subject to closing conditions.
www.lonza.com/media-advisories/2025-10-27-15-00 -
Lonza
@LonzaGroup
In our Q3 qualitative update, we reported a strong performance and confirmed our upgraded Full-Year 2025 Outlook for both our CDMO business, and our Capsules & Health Ingredients (CHI) business.
www.lonza.com/news/2025-10-23-06-30 -
Lonza
@LonzaGroup
We have been awarded a Gold medal in the EcoVadis Sustainability rating, with a score putting us in the top 5% of companies assessed.
#lonza #cdmo #sustainability #ecovadissuccessstory #esg -
Lonza
@LonzaGroup
Today, we announced a collaboration with RION to provide cGMP manufacturing and technical support for commercial scale production of its Purified Exosome Product™ (PEP™) drug substance for late phase clinical supply and beyond.
Read more: www.lonza.com/media-advisories/2025-09-23-14-00 -
Lonza
@LonzaGroup
We have seen a strong financial performance in H1 2025, with CHF 3.6 billion sales resulting in 19.0% CER sales growth, and a CORE EBITDA of CHF 1.1 billion resulting in a robust margin of 29.6%.
Read more about our progress in H1 2025 here: www.lonza.com/news/2025-07-23-06-30 -
Lonza reposted
Business at OECD
@BusinessatOECD
📢 We are delighted to announce that @LonzaGroup's Chief #legal & Corporate Affairs Officer Andreas Bohrer has joined as a Member of our Executive Board to help advocate our mission at the @OECD.
Nominated by our member @economiesuisse, Andreas brings a wealth of experience in legal affairs from his time at #lonza.
🔎 Our Executive Board ➡️ businessatoecd.org/executive-board -
Lonza
@LonzaGroup
We have just launched our Design2Optimize™ platform, to enhance the process development and manufacturing of small molecule APIs.
www.lonza.com/media-advisories/2025-05-22-14-00 -
Lonza
@LonzaGroup
In our Q1 qualitative update, Lonza reported a strong performance in line with expectations for Full-Year 2025, driven by robust commercial demand in our CDMO business and high utilization in the early-stage business.
www.lonza.com/news/2025-05-09-06-30 -
Lonza
@LonzaGroup
Today we published our Annual Report 2024 and Sustainability Report 2024, giving a comprehensive overview of our progress towards our long-term business and sustainability goals.
www.lonza.com/news/2025-04-03-07-00 -
Lonza
@LonzaGroup
Today we launch our simplified and streamlined operating model. Based on our “One Lonza” vision and strategy, this transformation unites our core competencies to fulfil our vision to be a pioneer and world leader in the CDMO industry.
www.lonza.com/news/2025-04-01-14-00 -
Lonza
@LonzaGroup
Today, we reported our financial results for Full-Year 2024, with sales of CHF 6.6 billion. A CORE EDITDA of CHF 1.9 billion resulted in a robust margin of 29.0%, driven by high demand for commercial CDMO services and strong operational execution.
www.lonza.com/news/2025-01-29-06-25 -
Lonza
@LonzaGroup
Looking for your next opportunity? We’ve just launched our brand new careers site, designed to make finding and applying for your next role easier than ever.
Visit lonza.com/careers to see how you could make an impact with us. -
Lonza
@LonzaGroup
We have just expanded our service offering for orally delivered biologic therapies to support the unique development and manufacturing needs of smart capsules companies.
www.lonza.com/media-advisories/2024-12-03-14-00 -
Lonza
@LonzaGroup
We have just completed the first GMP product batch supported from our recently completed next-generation mammalian manufacturing facility in Portsmouth (US).
www.lonza.com/media-advisories/2024-11-20-14-00 -
Lonza
@LonzaGroup
In our Q3 qualitative update, we reported performance is on track to deliver on our Full-Year Outlook, with a strong Q3 commercial and operational performance across the CDMO business.
www.lonza.com/news/2024-10-24-07-00 -
Lonza
@LonzaGroup
Today, we completed our acquisition of the Genentech biologics manufacturing site in Vacaville, California from Roche for USD 1.2 billion.
The Vacaville facility significantly extends our mammalian manufacturing footprint in the US, the world’s largest pharmaceutical market. -
Lonza
@LonzaGroup
We have just signed a long-term commercial supply agreement for CASGEVY® with Vertex Pharmaceuticals.
We will manufacture CASGEVY® at our cGMP cell therapy manufacturing facilities in Geleen (NL), with plans to expand to our Portsmouth (US) facility.
www.lonza.com/news/2024-09-24-14-00 -
Lonza
@LonzaGroup
Today, we inaugurated our newest facility - the Innovaform Accelerator, to serve as a Center of Excellence for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.
www.lonza.com/media-advisories/2024-09-19-14-00 -
Lonza
@LonzaGroup
We have just completed an expansion of our mid-scale microbial manufacturing facility in Visp, Switzerland.
The new facility enhances our microbial manufacturing scale flexibility and will allow us to meet a broad range of drug developers' needs.
www.lonza.com/media-advisories/2024-09-05-14-00 -
Lonza reposted
Embassy of Switzerland in Singapore
@SwissAmbSGP
Very honored to attend @LonzaGroup Safety & Wellness Day! Hugely impressed by Lonza‘s commitment to safety and wellbeing of its over 1000 employees in 🇸🇬! A great example of a🇨🇭company contributing to the lion city! Thanks also to @SCDF for their presence!
-
Lonza
@LonzaGroup
We have just added clinical bottling and labeling capabilities at our Small Molecules site in Bend, Oregon (US), enabling us to speed up product delivery to clinical trial centers, which is crucial in its customers' journey toward clinical trials.
www.lonza.com/media-advisories/2024-08-06-14-00 -
Lonza
@LonzaGroup
Today we reported solid financial results for the first half of 2024. With sales of CHF 3.1 billion for H1 2024, with our business performance well on track to deliver our Full-Year Outlook.
Read more: www.lonza.com/news/2024-07-25-06-55 -
Lonza
@LonzaGroup
We have just launched our AI-enabled Route Scouting Service, which aims to streamline synthetic route identification for novel APIs by combining our global chemical supply chain intelligence and in-house expertise with AI technology from Elsevier.
www.lonza.com/media-advisories/2024-04-29-14-00 -
Lonza
@LonzaGroup
Today we published our 2023 Annual Report and 2023 Sustainability Report. To learn more, visit: www.lonza.com/annualreport/2023/
-
Lonza
@LonzaGroup
Wolfgang Wienand has been appointed as our new Chief Executive Officer (CEO) and will join Lonza this summer. Wolfgang is currently CEO of Swiss CDMO Siegfried, a role he has held since 2019.
www.lonza.com/news/2024-04-02-07-00 -
Lonza
@LonzaGroup
We have expanded our service offering for spray-drying of proteins for pulmonary delivery. The new offering provides clinical and commercial manufacturing services from Lonza’s Bend (US) site, home to Lonza’s Center of Excellence for respiratory delivery.
www.lonza.com/media-advisories/2024-03-27-14-00 -
Lonza
@LonzaGroup
This morning, we announced that we have signed an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Roche for USD 1.2 billion subject to regulatory approvals.
Read more: www.lonza.com/news/2024-03-20-07-00 -
Lonza reposted
GENEGUT
@GENEGUT_EU
"Regional delivery will be transformative for the treatment of Crohn's disease" In this #genegutexplains, Dr. Vincent Jannin (Lonza) and Prof. Brendan Griffin (@Pharmacy_UCC) explain the concept of #regionaldelivery and why it is crucial for GENEGUT. Watch the video below 👇
-
Lonza
@LonzaGroup
We have entered into a collaboration with Oxford Nanopore, a company delivering a new generation of nanopore-based molecular sensing technology.
Read more: www.lonza.com/media-advisories/2024-01-30-09-00 -
Lonza
@LonzaGroup
We are proud to announce we have secured an industry-first, renewable power agreement in China together with four global health companies AstraZeneca, Novartis, Novo Nordisk, Roche and renewable energy leader Envision Energy.
Learn more: www.lonza.com/media-advisories/healthcare-leaders-secure-… -
Lonza
@LonzaGroup
We have just launched the TheraPRO® CHO Media System, a new cell culture platform that simplifies processes and optimizes productivity and protein quality when used with GS-CHO cell lines.
Read more: www.lonza.com/news/2023-07-17-14-00 -
Lonza
@LonzaGroup
We have entered a collaboration with Vertex to support the manufacture of its portfolio of T1D investigational cell therapies, including process development and scale-up, as well as co-investing to build a dedicated new facility in Portsmouth, NH.
www.lonza.com/news/2023-06-26-13-30 -
Lonza
@LonzaGroup
Lonza's Virtual Power Purchase Agreement with IGNIS will produce energy equal to Lonza’s electricity needs across Switzerland and the EU. It marks an important step in our ambition to source all power from renewable sources by 2025. www.lonza.com/sustainability/agreement-produce-solar-elec… #ahealthierworld
-
Lonza
@LonzaGroup
Lonza has aquired Synaffix, an innovative biotech company focused on antibody-drug conjugates. The acquisition will further strengthen our bioconjugates offering by integrating the proprietary Synaffix technology platform and R&D capabilities:
www.lonza.com/news/2023-06-01-07-00 -
Lonza
@LonzaGroup
Recently, Lonza’s Deanna Mudie and John DiBella from Simulations Plus discussed Lonza's new PBPK modeling software for mitigating absorption risks in early drug development.
To find out more, view the on-demand webinar: www.lonza.com/knowledge-center/smallmolecules/w/pbpk-mode…
#lonzasm #pbpk #weworkasone -
Lonza
@LonzaGroup
In our Q1 Qualitative Update, we reported performance in line with our 2023 Full-Year trajectory.
Operations commenced in two new facilities in Visp (CH), while construction began at the facility in Stein (CH).
Read more here: www.lonza.com/news/2023-05-10-07-00 -
Lonza
@LonzaGroup
Our #cellandgene expert Behnam Ahmadian Baghbaderani will be delivering a presentation at the iPSC Manufacturing Summit in Boston this week. He is looking forward to networking with peers along with our colleagues Elaine Rihn and Marcos Langtry who will also be attending.
-
Lonza
@LonzaGroup
At CPHI North America, Deanna Mudie and Josh Marsh will be presenting on how PBPK models can be combined with a range of other tools to highlight potential problems with absorption at an early stage.
Join us on Tuesday, April 25th, at 10am in room 201A.
#lonzasm #weworkasone -
Lonza
@LonzaGroup
Lonza's Deanna Mudie and John DiBella from Simulations Plus will be hosting a webinar on April 27 to discuss how PBPK modelling can identify and mitigate absorption risk in early drug development.
Join us at 11am EDT:
event.on24.com/wcc/r/4123022/6EE021012A92603C45A42463404E…
#lonzasm #pbpk #weworkasone -
Lonza
@LonzaGroup
Lonza will be exhibiting at CPHI North America from 25-27 April. Visit our team at Booth #459 to discuss your project requirements. Two of our scientists will also be speaking about PBPK modeling at the conference on the Tuesday morning.
#lonzasm #smallmolecules #weworkasone -
Lonza
@LonzaGroup
We are collaborating with ABL Bio, a pioneering Korean biologics company with a focus on bispecific antibodies for immuno-oncology and neurodegenerative diseases, to support the development and manufacturing of ABL Bio's new bispecific antibody product.
www.lonza.com/media-advisories/2023-04-04-14-00 -
Lonza
@LonzaGroup
In a recent webinar, Abhijeet Sinha, talked about the importance of solid form services as a bridge between drug substance and drug product when developing a new drug.
You can view the on-demand presentation here: go2.lonza.com/mkform-sv-smm-fih-0423-sfs-webinar.html
#lonzasm #solidformservices #weworkasone -
Lonza
@LonzaGroup
We have just published our 2022 Sustainability Report, which provides insights into our renewed commitments and performance relating to the most relevant sustainability topics for our business, stakeholders and communities.
Find out more: www.lonza.com/annualreport/2022/sustainability -
Lonza
@LonzaGroup
We have just published our 2022 Annual Report and 2022 Sustainability Report. To learn more about our performance and milestones this year, read our 2022 Annual Report: www.lonza.com/annualreport/2022/
-
Lonza reposted
Hedda Samson
@HeddaSamson
Excellent exchange with @LonzaGroup CEO Pierre-Alain Ruffieux and topmanagers Andreas Bohrer and Daniel Palmacci in Basel 🇨🇭 this morning. Very proud to have Lonza at the @BL_Chemelot Campus in #geleen 🇳🇱 for its Cell&Gene business! 🙏🏼 @nfiaholland
-
Lonza
@LonzaGroup
Next week, Lonza's Abhijeet Sinha will be talking about the importance of solid form services as a bridge between drug substance and drug product when developing a new drug.
Register here: event.on24.com/wcc/r/4095834/055C4A044C6E0495165D886371F5…
#lonzasm #solidformservices #weworkasone -
Lonza reposted
Financial Times Live
@ftlive
On 22 March, join experts from @moderna_tx, @LonzaGroup, @Atarabio and @Cytiva as they discuss innovative ways to expedite and improve biomanufacturing and ensure the next generation of advanced therapies can reach patients affordably and at scale: manufacturingtherapies.live.ft.com
-
Lonza
@LonzaGroup
A recent webinar given by Hannah Sullivan and Joel Wood provided insight into multiparticulate technology, and when it’s a good choice for a new dosage form.
You can watch the on-demand version here: www.lonza.com/knowledge-center/smallmolecules/w/multipart…
#lonzasm #multiparticulates #weworkasone -
Lonza
@LonzaGroup
We have just completed an expansion of our bioconjugation facility in Visp, CH. It will support an extended customer portfolio, including companies entering clinical development.
Read more: www.lonza.com/news/2023-02-16-14-00 -
Lonza
@LonzaGroup
Join Duke Chalker and Nick Appel at PharmScience Research & Development from February 21-23, in Las Vegas, NV.
We are looking forward to connecting with experts from across the industry and building new partnerships.
#pharmar&D #smallmolecules #weworkasone -
Lonza
@LonzaGroup
We are expanding our Early Development Services (EDS) offering by opening a new facility in Cambridge, Massachusetts (US) in May 2023.
Read more: www.lonza.com/media-advisories/2023-02-13-14-00 -
Lonza
@LonzaGroup
Innovation at Lonza is driven by #womeninscience, everyday. Together we work to enable a healthier world.
Read our stories from women scientists at Lonza: www.lonza.com/careers/life-at-lonza/career-stories
#ameaningfuldifference -
Lonza
@LonzaGroup
We will be attending Biotechgate Digital Partnering from 6-10 February to connect with experts across the #pharma, #biotech, and digital health space.
Join Eva Vazquez for a one-on-one session to learn more about Lonza’s offerings: www.digitalpartnering.com
#weworkasone -
Lonza
@LonzaGroup
Our Head of Digital Transformation Stephan Rosenberger penned his perspective in @GENbio on the state of “Industry 4.0” in the pharmaceutical industry and the role of #ai and machine learning in today’s CDMO operations.
Read the full article here: www.genengnews.com/topics/drug-discovery/growth-of-artifi… -
Lonza
@LonzaGroup
Today, we announced a strong set of Full-Year Results for 2022, with sales of CHF 6.2 billion and CHF 2.0 billion CORE EBITDA, resulting in a margin of 32.1%.
Read more: www.lonza.com/news/2023-01-25-07-00 -
Lonza
@LonzaGroup
Our #smallmolecules expert spoke with @dddmag on key trends to follow in 2023 from AI and machine learning to solving the increasing complexity of small molecules. Learn more about what to expect here: www.drugdiscoverytrends.com/small-molecule-trends-to-foll…
-
Lonza
@LonzaGroup
Bispecific antibodies (bsAbs) can help shape how we treat cancer and other diseases. Hear from our biologics experts in @PharmaReview on how to achieve accelerated timelines & overcome manufacturing challenges during cell line development.
Learn more: www.europeanpharmaceuticalreview.com/upstream-processing/… -
Lonza
@LonzaGroup
We have just entered into a manufacturing agreement with Context Therapeutics to support the development and manufacturing of Context's bispecific antibody clinical candidate, targeting CLDN6 positive tumors.
Read more here: www.lonza.com/media-advisories/lonza-context-therapeutics… -
Lonza
@LonzaGroup
The CDMO market is facing an increasing demand for fill and finish production as new drug approvals are being fueled by small biotechs.
Our expert, Peter Droc, spoke with @BioProcessIntl on current demand and what to expect in 2023.
Read more here: www.bioprocessintl.com/global-markets/the-cdmo-space-does… -
Lonza reposted
European Innovation Council
@EUeic
The #eueic plays a crucial role in nurturing the connection between #startups and industry. 🚀
Hear from @LonzaGroup 🇨🇭 about their experience with the EIC Corporate Day and how these events foster #innovation.
Read more here 👉 eic.eismea.eu/community/stories/stories-eic-corporate-cor… -
Lonza
@LonzaGroup
Happy New Year from Lonza!
#ameaningfuldifference #ahealthierworld -
Lonza
@LonzaGroup
Sustainability continues to be priority for Lonza as we help reduce emissions and waste. Hear from our #smallmolecules experts about methodologies and successes behind wastewater incineration reduction.
Learn more here: www.lonza.com/knowledge-center/smallmolecules/w/process-r… -
Lonza
@LonzaGroup
Hear from our experts in the @medicine_maker on how the pharma industry can prepare for the growing demand for ADCs in oncology and other therapeutic areas and build HPAPI suites for the future. Learn more here: themedicinemaker.com/discovery-development/is-pharma-on-t…
-
Lonza
@LonzaGroup
Our Lonza team will be attending @DDLConferences from 7-9 December in Edinburgh, UK. Visit our booth (#348) to learn more about our capabilities in the respiratory drug delivery space.
Learn more here: ddl-conference.com
#weworkasone -
Lonza
@LonzaGroup
Interested in learning more about how we're reducing the environmental impact of small molecules production? Our #smallmolecules experts will host a webinar highlighting our approach to wastewater treatment.
Tune in on December 5th at 10am EST/4pm CET: event.on24.com/wcc/r/3964060/D2FB7E065F2C6CA4C44B6938F97A… -
Lonza
@LonzaGroup
Our #biologics R&D expert Brandon Downey shared his insights with @BioPharmReport about N-1 perfusion and its capability to achieve process intensification. Read his insights on the process' advantages and solutions to potential challenges here.
-
Lonza
@LonzaGroup
Our #smallmolecules expert Abhijeet Sinha recently shared his perspective with @PharmaReview about how an integrated strategy for early phase development can help meet accelerated timelines and position products for commercial success.
www.europeanpharmaceuticalreview.com/page-deleted
#weworkasone -
Lonza
@LonzaGroup
Our viral vectors expert Suparna Sanyal wrote a piece in @medicine_maker on navigating the rising demand for lentiviral and adeno-associated viral (AAV) vectors and the type of capabilities needed to scale-up these innovative therapies.
Learn more here: themedicinemaker.com/manufacture/the-pros-and-cons-of-len… -
Lonza
@LonzaGroup
Our Drug Product Services expert shares with @BioPharmIntl how the pandemic disrupted the biopharma industry and how CDMOs are assessing the resilience of their manufacturing networks and supply chains. Learn more here: www.biopharminternational.com/view/focus-on-fill-and-finish
-
Lonza
@LonzaGroup
We have just launched an innovative new capsule solution for intestinal (enteric) drug delivery. The Capsugel® Enprotect™ capsule does not disintegrate during stomach transit and only releases its contents in the intestine.
Read more: www.lonza.com/news/2022-11-01-07-00 -
Lonza
@LonzaGroup
Our Lonza team will be attending #cphifrankfurt from 1-3 November.
Interested in learning more about our capabilities? Visit us at our booth (90F10) to learn more: www.cphi.com/europe/
#weworkasone -
Lonza
@LonzaGroup
Our experts Jason Bertola and Travis Harrer recently hosted an in-depth discussion about spray drying technology and Lonza’s approach to using this technology for scale-up programs.
Tune in here: www.lonza.com -
Lonza
@LonzaGroup
Interested in learning more on ADCs? Hear from our ADC expert, Charles Johnson, on key market trends in producing ADCs and Lonza’s approach to lifecycle investment.
Tune in on October 27 here: globalmeet.webcasts.com/starthere.jsp?ei=1560140&tp_key=e… -
Lonza
@LonzaGroup
Our #smallmolecules team will be at @AAPSComms from October 16-19 and our experts, David Lyon and Deanna Mudie, will be hosting presentations focused on localized lung cancer treatment and amorphous solid dispersions.
Join us and learn more here: go2.lonza.com/sv-smm-aaps-2022.html -
Lonza
@LonzaGroup
Two cell and gene therapies manufactured at Lonza Houston reach US FDA approval in short succession, in Q3 2022.
The therapies are both developed by bluebird bio of Somerville, MA and were approved by the FDA in August and September, respectively.
www.lonza.com/news/2022-10-06-14-00 -
Lonza
@LonzaGroup
Our #smallmolecule team will be at at Formulation & Delivery U.S. from October 11-12 and our expert, David Lyon, will be hosting a session on amorphous solid dispersions.
Join us and learn more here: oxfordglobal.com/discovery-development/ -
Lonza
@LonzaGroup
125 years, one Lonza.
This October, we celebrate our 125th anniversary. Since 1897, we have harnessed emerging technologies to meet new customer needs, kept pace with change and made a meaningful difference to the world around us.
#lonza125 #ameaningfuldifference #history -
Lonza
@LonzaGroup
Our #bioavailability expert Deanna Mudie penned an article in @ContractPharma about how amorphous solid dispersions (ASDs) can help enhance the bioavailability of oral #smallmolecule drugs. Read her insights here. www.contractpharma.com/contents/view_online-exclusives/20…
-
Lonza
@LonzaGroup
Hear from our #smallmolecules toxicologist expert, Lisa Wiesner, at the HPAPI Handling and Manufacturing Summit 2022. Lisa will be presenting on HBELs for HPAPIs. Register and learn more here: www.uventia.com/event/2nd-hpapi-handling-manufacturing-su…
-
Lonza
@LonzaGroup
Our antibody drug conjugate (ADC) experts talked to @BioProcessIntl about our recent expansion of HPAPI services at our Visp site and how it will support the pipeline of services to produce ADC payloads.
Read the full article here: www.bioprocessintl.com/bioprocess-insider/facilities-capa… -
Lonza
@LonzaGroup
Our #smallmolecules team will be heading to @DDF_Summit from September 26-27. Our expert, David Lyon, will also be hosting a presentation on amorphous solid dispersions (ASDs) and their effect on bioavailability.
Learn more here: ddfsummit.com/program-2022 -
Lonza
@LonzaGroup
Our Cell and Gene Therapy experts shared their insights with @BioPharmIntl on adventitious agent testing for viral vectors and best practices for selecting the appropriate testing method. Learn more here: www.biopharminternational.com/view/adventitious-agent-tes…
-
Lonza
@LonzaGroup
Lonza’s #biologics expert Carrie Mason shares her insights on how to streamline the bulk manufacture of monoclonal antibodies with @BioPharmIntl. Read how processes with Quality by Design can help create consistent antibodies for commercial scale up. www.biopharminternational.com/view/streamlining-bulk-mab-…
-
Lonza reposted
Embassy of Switzerland in the USA
@SwissEmbassyUSA
The #soireesuisse returned to its traditional in-person format, thanks in part to the work of @LonzaGroup and @moderna_tx, it was a great honor to present the 2022 Tell Award for their pioneering collaboration and immense contributions to the fight against the global pandemic.
-
Lonza
@LonzaGroup
Less than one week until CAR TCR 2022 conference in Boston, are you attending? Lonza is the lead sponsor of the 7th CAR-TCR Summit, organized by Hanson Wade. Visit us at our booth, #d67 to meet our experts. Schedule a meeting with our team: go2.lonza.com/sv-cgt-car-t-cr-2022.html
-
Lonza
@LonzaGroup
Hear from our #smallmolecules expert, Deanna Mudie, at Disso America 2022 on how to design dissolution media to support biopredictive dissolution testing.
Register and learn more here: spds.us -
Lonza
@LonzaGroup
We have completed an expansion of our Highly Potent API multipurpose suite in Visp. The expansion adds development and manufacturing capacity for antibody-drug conjugate payloads, supporting the entire development and manufacturing pipeline.
Read more: www.lonza.com/news/2022-09-14-14-00 -
Lonza
@LonzaGroup
We have just announced a collaboration with @TouchlightDNA to integrate an additional, differentiated source of DNA in our end-to-end offering to customers developing messenger RNA (mRNA) therapeutics and vaccines.
Read more: www.lonza.com/news/2022-09-06-07-00 -
Lonza
@LonzaGroup
Our microbial expert shared his perspective with @GENbio on how to navigate challenges the industry faces in bioprocessing monitoring and control operations. Learn more about our quality-by-design approach and process analytical technology here: www.genengnews.com/topics/bioprocessing/lonzas-perspectiv…
-
Lonza
@LonzaGroup
Our solubility expert shares the role of particle size reduction and amorphous solid dispersions (ASDs) in addressing low or poor solubility. These innovations are essential to the maintaining a robust drug development pipeline. Read the full article here: www.pharmtech.com/view/adapting-to-solubility-bioavailabi…
-
Lonza
@LonzaGroup
More than 25% of drugs worldwide are formulated with highly potent APIs, and 60% of those are cancer therapies. Our #smallmolecules expert David Lyon spoke with @PharmTechGroup about addressing several HPAPI formulation challenges.
Read more here: www.pharmtech.com/view/challenges-to-formulation-developm… -
Lonza
@LonzaGroup
In an article for BioPharm International, our #biologics expert Stéphane Varray discusses taking a Biologics drug through the manufacturing and regulatory journey, and how careful planning can save companies months of wasted time and money.
Read more: www.biopharminternational.com/view/outlining-successful-s… -
Lonza
@LonzaGroup
Hear from our expert, Molly Adam, who will be presenting at #acsfall2022 who will discuss the benefits of using processing aids during #spraydrying process for producing ASDs.
Learn more about the event here: www.acs.org/content/acs/en/meetings/acs-meetings/fall-202… -
Lonza
@LonzaGroup
On August 25th, hear from our experts about how technologies such as ASDs can transform poorly soluble compounds and improve their bioavailability.
Register for the webinar here: www.cphi-online.com/webinar/improved-delivery-of-poorly-s… -
Lonza
@LonzaGroup
Our #smallmolecule experts Jason Bertola & Kathryn Schwiebert spoke with @Chemicalweek about our new facilities in Bend, OR, dedicated to early-phase manufacturing. The additional capacity will help to address the bioavailability challenge in early stages. chemweek.com/document/show/phoenix/4493217/Lonza-addresse…
-
Lonza
@LonzaGroup
Hear from our ADC expert, Charles Johnson, on the need to scale up production of ADC payloads and how Lonza is strategically investing to meet demand.
Register and join the webinar on August 31 here: globalmeet.webcasts.com/starthere.jsp?ei=1560140&tp_key=e… -
Lonza
@LonzaGroup
Today we reported solid financial results for the First Half of 2022, with sales of CHF 3 billion and 16.8% CER sales growth, thanks to the commitment of our colleagues across our global network.
Read more: www.lonza.com/news/2022-07-22-07-00 -
Lonza
@LonzaGroup
Our #smallmolecules expert Kimberly Shepard shares with Pharma’s Almanac our work with spray drying monoclonal antibodies for dry powder inhalation and highlights numerous benefits, such as reduced dose and systemic side effects.
Learn more. www.pharmasalmanac.com/articles/in-which-orphan-spaces-or… -
Lonza
@LonzaGroup
Hear from Head of Lonza China, Hong Pan, who shared with @medicine_maker current trends shaping China’s growing pharmaceutical industry and the important role of CDMOs to help support growth.
Learn more here: themedicinemaker.com/business-regulation/chasing-harmony -
Lonza
@LonzaGroup
Our #smallmolecules expert Silke Erbeck discusses with Pharma’s Almanac how Lonza approaches challenges in the supply chain and ensures backup solutions and security through a fully integrated offering.
Learn more: www.pharmasalmanac.com/articles/what-do-you-consider-the-… -
Lonza
@LonzaGroup
We are pleased to announce that Maria Soler Nunez will join Lonza on 1 August 2022 as Head, Group Operations and member of the Executive Committee.
Read more: www.lonza.com/news/2022-07-01-08-00 -
Lonza
@LonzaGroup
We have just announced our plans to build a large-scale, commercial drug product fill & finish facility in Stein, Switzerland.
Read more: www.lonza.com/news/2022-07-01-07-00 -
Lonza
@LonzaGroup
Last week, Kim Shepard shared her perspective on applications and indications where dry powder inhaler combinations can be implemented. If you would like to learn more about these therapies and the approach, you learn more here: www.lonza.com
-
Lonza
@LonzaGroup
Join our experts at OCTS this week at booth #11. Featuring Steven Bouman, Senior Manager, Business Development, who will be moderating a panel discussion about some best practices of cell therapy manufacturing on June 30, at 1.55pm EST.
-
Lonza
@LonzaGroup
Our Mammalian expert Jennifer Cannon spoke with @GBReports about recent investments and initiatives to address current industry trends to support the development of complex novel biotherapeutics. Read her perspective here: www.gbreports.com/files/pdf/_2022/USALifeSciences-2022-IE…
-
Lonza
@LonzaGroup
Next week June 28-30, Eric Blomgren and Elizabeth Herder from our #smallmolecules team will be at the HPAPI Summit in Boston. They look forward to discussing how Lonza supports the manufacture of highly potent compounds. musictheoryworkshop.com
-
Lonza
@LonzaGroup
Join our #smallmolecules team at the DDF Summit on 27-29 June at booth 4 and hear about the latest innovation and breakthroughs in the drug and formulation development stages.
ddfevent.com/live/en/page/home -
Lonza
@LonzaGroup
Last week, Maureen Kadleck presented a webinar about particle engineering for inhaled #drugproducts. Through a case study, she shared how to advance from clinical studies to commercialization. Watch the on-demand version here:
www.lonza.com -
Lonza
@LonzaGroup
Our #biologics experts Nikki Nogal and Ahmad Sediq share their insights about bispecific antibodies and how to bring them to the clinic through a robust understanding of their science as well as a strategy to reduce immunogenicity. Read more here: www.biopharminternational.com/view/bispecific-antibodies-…
-
Lonza
@LonzaGroup
Next week, our inhalation expert Kim Shepard will present during a webinar about recent developments in spray drying technology and discuss how this technology enables challenging combination DPI therapies to be developed. event.on24.com/wcc/r/3807724/B466A09877C592386F533FE5722F…
-
Lonza
@LonzaGroup
Our scientists will be at ISSCR 2022 this week! Visit us at booth #409 or reach out in advance at pharma@lonza.com to schedule a meeting.
#realizingtogether #celltherapy #genetherapy -
Lonza
@LonzaGroup
Flexibility, expertise and an ability to solve problems and keep projects on track have proved invaluable to many of our small biotech partnerships.
Read more about why Pionyr chose Lonza to help: www.pharmasalmanac.com/articles/tuning-the-myeloid-compar… -
Lonza
@LonzaGroup
Our #inhalation expert Maureen Kadleck will be presenting a webinar about particle engineering for inhaled drug products. Join us as she discusses a case study about gemcitabine as an inhaled lung cancer treatment. Sign up here: event.on24.com/eventRegistration/unavailable?&eventid=382…
-
Lonza
@LonzaGroup
Our #bioconjugates expert Stefan Egli spoke with @cenmag on the emerging technologies with antibody-drug conjugates, including stabler linkages and improved toxicity profiles.
Read more: cen.acs.org/pharmaceuticals/biologics/New-day-antibody-dr… -
Lonza
@LonzaGroup
Our #hpapi expert Christian Noti spoke to @Chemicalweek about what is contributing to the rise in demand for HPAPIs, as well as what pharma companies can do to ensure they can safely scale up their HPAPI molecules. Read more here: chemweek.mydigitalpublication.com/may-23-30/page-39?m=666…
-
Lonza
@LonzaGroup
We have just launched our new Non-endotoxin Pyrogen detection system – the PyroCell® Monocyte Activation Test. This new system provides a more sensitive detection of non-endotoxin pyrogen contaminants and improves the sustainability of pyrogen testing.
www.lonza.com/news/2022-06-07-14-00 -
Lonza
@LonzaGroup
Hear from our #biologics expert Jennifer Cannon who discussed with @pharmaboardroom how we reimagine new models to address industry trends, effects of the pandemic on the industry and demand for new capabilities to accelerate timelines.
Read more here. -
Lonza
@LonzaGroup
In 2021, we continued to reduce our energy consumption, carbon footprint and waste disposal, while focusing on renewable energy resources. These activities will have a transformative long-term impact on our environmental footprint.
Find out more: www.lonza.com/investor-relations/-/media/9676177FE6F64D4A… -
Lonza
@LonzaGroup
Our experts Roman Mathaes and Cristina Grigore shared their insights on biologic drugs’ late-phase development. With a strategic view on this stage, companies can bring down the cost of their biologic's product development and launch.
Read it here: proteomics.lifesciencesreview.com/cxoinsight/partnering-w… -
Lonza
@LonzaGroup
We have completed an expansion of our site in Bend, OR. The new dedicated Early Phase Clinical Manufacturing facility at the site will enhance our offering for customers in the early phases of clinical trials and enables us to speed up product delivery.
www.lonza.com/news/2022-06-01-14-00 -
Lonza
@LonzaGroup
Selecting the right partner is critical to helping advance compounds through each stage of development. Hear from our #smallmolecules experts on how having the necessary flexibility and capabilities are critical to meeting milestones.
Learn more: www.lonza.com -
Lonza
@LonzaGroup
Our #smallmolecules expert Jan Vertommen spoke with @medicine_maker about the strategic advantages of our facilities in China, and how our recent #hpapi investments at our Nansha site expands our integrated global HPAPI offering.
Read it here: themedicinemaker.com/manufacture/dont-worry-be-hpapi -
Lonza
@LonzaGroup
Experts in the biopharmaceutical industry are addressing the challenges of manufacturing monoclonal antibodies. Our #biologics expert Jeetendra Vaghjiani discusses with @PharmTechGroup how capacity constraints can cause bottlenecks.
Learn more here: www.pharmtech.com/view/speeding-up-development-for-tradit… -
Lonza
@LonzaGroup
We are working with Israel Biotech Fund to support the development and manufacture of biologics and small molecules for IBF’s portfolio companies.
Read more: www.lonza.com/news/2022-05-24-14-02 -
Lonza
@LonzaGroup
Hear from our #smallmolecules experts during an informative webinar on May 25th about the importance of enlisting a partner with integrated capabilities to help advance complex compounds during clinical drug development.
Register here: event.on24.com/wcc/r/3743322/17E65BF5BF7FE2E2B72D7A4F58AD…
#weworkasone -
Lonza
@LonzaGroup
To meet a rising need the need for improved localized delivery, we are expanding our inhalation capabilities at our Tampa site in Florida, US. The investment will fund the build-out of an additional inhalation testing capacity at the site.
Read more: www.lonza.com/news/2022-05-23-14-00 -
Lonza
@LonzaGroup
Our #smallmolecules expert spoke with @CHEManager_EU about the current trends in small molecule and HPAPI manufacturing, and how the right CDMO partner can provide reduced timelines, streamlined services, improved technical transfer and more.
Learn more: chemanager-online.com/en/news/integrated-drug-development… -
Lonza
@LonzaGroup
We have just opened Kodiak Science’s purpose-built Bioconjugation Facility at our Ibex® complex in Visp, CH. The facility will support the potential commercial launch of Kodiak’s lead product candidate KSI-301.
Read more: www.lonza.com/news/2022-05-18-14-00 -
Lonza
@LonzaGroup
Our particle engineering expert Salvatore Mercuri shared his insights with @medicine_maker about micronization. As a bioavailability enhancing technology, he noted that it is especially useful for DPI applications.
Read more about it here. themedicinemaker.com/manufacture/small-but-mighty
#weworkasone -
Lonza
@LonzaGroup
Join us at ASGCT's Annual Meeting this week in Washington DC. Visit us at booth #570 or reach out in advance at pharma@lonza.com to schedule a meeting.
Looking forward to meeting many of you there!
#asgct22 #cellthereapy #genetherapy -
Lonza
@LonzaGroup
Join us from May 17-19, where our #smallmolecules team will head to Philadelphia, PA to attend #cphina. The team looks forward to meeting with industry leaders from every aspect of the pharma supply chain.
Register and learn more here: www.cphi.com/americas/
#weworkasone -
Lonza
@LonzaGroup
Our #smallmolecules business experts will be at Biomed Israel Conference and Exhibition from May 10-12. They'll be connecting with other industry leaders about current trends and innovations shaping the future of our industry. kenes-exhibitions.com/biomed/
#weworkasone -
Lonza
@LonzaGroup
Lonza will collaborate with ALSA Ventures to help their portfolio of pre-clinical and early clinical biotechs develop and manufacture biologics and small molecule drug candidates. Read the full release here: www.lonza.com/news/2022-05-09-14-00
-
Lonza
@LonzaGroup
We are excited to announce titanium dioxide-free (TiO2-free) white hard gelatin capsules. These fulfill an evolving demand of our customers to meet requirements for foods in the European Union. Read more via www.lonza.com/news/2022-05-09-10-00
-
Lonza
@LonzaGroup
Our #smallmolecules team looks forward to attending the Biotechgate Digital Partnering event from May 9-13 and virtually meeting with business development and licensing leaders in the pharma and biotech sectors. Register and learn more here: www.digitalpartnering.com
#weworkasone -
Lonza
@LonzaGroup
In a recent article by @Chemicalweek, our VP of Commercial Development for Small Molecules Christian Dowdeswell explained why around 70% of FDA approvals are small molecules. Read the full article to learn more: chemweek.com/document/show/phoenix/4346574/Fortifying-API…
-
Lonza
@LonzaGroup
We are excited to attend the LSX World Congress 2022 next week and look forward to meeting with industry leaders to discuss the latest cutting-edge research.
Register and learn more here: informaconnect.com/investival-europe/
#enablingahealthierworld -
Lonza
@LonzaGroup
Listen to our latest podcast episode featuring Lonza's Iwan Bertholjotti and Laurence Bonnafoux to get A View On Antibody-Drug Conjugates, their history, applications and manufacturing: www.youtube.com/watch?v=jpgizJU2788
#aviewon #podcast #innovation #adcs -
Lonza
@LonzaGroup
On May 5-6, our #smallmolecules team will be attending Formulation & Delivery UK Congress in London to connect with leading industry experts about #formulation and #drugdelivery.
Register and learn more here: oxfordglobal.com/discovery-development/
#weworkasone -
Lonza
@LonzaGroup
Our #smallmolecules expert Jan Vertommen spoke with @OutsourcPharma about how the global growth in demand for APIs and HPAPIs has led to strategic partnerships and expansions, including HPAPI capabilities at out Nansha site.
Learn more here. www.outsourcing-pharma.com/Article/2022/04/21/Lonza-expan… -
Lonza
@LonzaGroup
Join us 4-5 May at the Anglonordic Life Science Conference to discuss the latest in investments in life science technologies. We look forward to connecting with our industry colleagues. Learn more here: www.anglonordiclifescience.com
-
Lonza
@LonzaGroup
Join our #smallmolecules team next week at #rdd2022 where we will be hosting a workshop on DPI formulation and connecting with industry leaders and researchers about the latest in pulmonary and nasal drug delivery. Learn more here: www.rddonline.com/rdd/rdd.php?id=21&sid=1
-
Lonza
@LonzaGroup
Next week, our #smallmolecules team will be attending Swiss Biotech Day on May 2-3. We look forward to meeting with biotech partners and experts from the life science industry. Learn more here: swissbiotechday.ch
-
Lonza
@LonzaGroup
Innovation, Integrity, Inclusion and Initiative.
Through our shared values we make a Meaningful Difference.
#ameaningfuldifference #ahealthierworld #valuesThis media couldn't be displayed. See it on the original post. -
Lonza
@LonzaGroup
Hear from our #smallmolecule experts David Lyon and Molly Adam, who discussed different enabling technologies designed to help improve drug solubility in organic solvents for spray drying. #weworkasone
Learn more:
www.lonza.com -
Lonza
@LonzaGroup
As part of our growing focus on emerging biotechs and bispecific antibodies, we have announced a collaboration with Asher Biotherapeutics to manufacture their immunotherapy molecule AB359.
www.lonza.com/news/2022-04-07-14-00 -
Lonza
@LonzaGroup
Join us on April 14, where our #smallmolecule experts discuss 3 different technologies that can help improve solubility in drug compounds. Register here: event.on24.com/wcc/r/3620200/E83BE425765AEFD68A818525E258…
#weworkasone -
Lonza
@LonzaGroup
Digital #manufacturing is key in improving efficiency. Stephan Rosenberger, Head of Digital Transformation Group Operations, spoke with @GENbio about how Lonza’s investment will help further meet the needs of customers. www.genengnews.com/topics/bioprocessing/going-digital-can…
-
Lonza
@LonzaGroup
Our #microbial expert, Axel Erler, shared his insights with @medicine_maker about how emerging and small biotechs can implement scale up and BLA activities to maximize success in a complex microbial biomanufacturing system.
Learn more here. themedicinemaker.com/manufacture/welcome-to-the-microbe-f… -
Lonza
@LonzaGroup
We have expanded the Cocoon® platform by including the Magnetic Selection capability. These new capabilities allow for cell binding, cell separation and bead removal.
Read more: www.lonza.com/news/2022-04-04-14-00 -
Lonza
@LonzaGroup
Our #smallmolecules expert, Christian Dowdeswell, spoke with Endpoints about how the expansion of our Nansha, China, site enables growth in HPAPI drug manufacturing and supports our recent partnership with Oasmia Pharmaceuticals.
Read more here: endpoints.news/qa-lonzas-christian-dowdeswell-talks-hpapi… -
Lonza
@LonzaGroup
Today, we announced our membership in the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS). This will allow us collaborate with other industry leaders to advance the development of inhalation technologies.
Read more: www.lonza.com/news/2022-03-31-14-00 -
Lonza
@LonzaGroup
Recently, our expert Jeetendra Vaghjiani spoke with @Labiotech.EU to share his view on why emerging biotech companies should engage with a CDMO early in development to help create a more efficient path to commercialization.
Read here. www.labiotech.eu/expert-advice/biotech-startups-manufactu… -
Lonza
@LonzaGroup
Today, we published our 2021 Sustainability Report, providing insights into our renewed commitments and performance related to the most relevant sustainability topics for our business and stakeholders.
Read more: www.lonza.com/investor-relations/-/media/9676177FE6F64D4A…
#ameaningfuldifference #sustainability -
Lonza
@LonzaGroup
To find out why 2021 was such an important year for Lonza, take a look at our 2021 Annual Report, published today.
Learn more about our performance and initiatives here: www.lonza.com/annualreport/2021/
#ameaningfuldifference #growth #lonza -
Lonza
@LonzaGroup
Our #smallmolecule and Capsule & Health Ingredients experts led an informative discussion on technologies used to help address bioavailability limitations of poorly soluble compounds.
Learn more here: www.lonza.com
#weworkasone -
Lonza
@LonzaGroup
Next week, we are excited to be at the #pbpworldmeeting to discuss the latest research in #pharma. Come visit us at our booth (#79) to learn more about new advancements in #smallmolecules.
Find out more here: www.worldmeeting.org/home/ -
Lonza
@LonzaGroup
Last week we had the pleasure of hosting the US Ambassador to Switzerland and Liechtenstein, Scott Miller, at our headquarters in Basel. We have over 15 sites in the US, and they play an important part in enabling #ahealthierworld.
-
Lonza
@LonzaGroup
We have just announced a manufacturing agreement with Oasmia Pharmaceutical AB for their ovarian cancer drug candidate, Cantrixil. Manufacturing will begin at our labs in Nansha, China, where we will deliver cGMP batches for clinical supply. Read more: www.lonza.com/news/2022-03-21-07-00
-
Lonza
@LonzaGroup
For the second year running, Lonza has been recognized by Ethisphere as one of the 2022 World’s Most Ethical Companies, recognizing the regulatory compliance, integrity and ethical conduct we place at the heart of our business practices. Read more: www.lonza.com/news/2022-03-15-12-00
-
Lonza
@LonzaGroup
Our Senior Group Leader in Drug Product Services, Ahmad Sediq, spoke with @GEN about how handling practices inform the formulation production of protein-based medicines, and what the RealHOPE project does to support this research. Read more here: www.genengnews.com/topics/bioprocessing/factoring-real-wo…
-
Lonza
@LonzaGroup
Our #smallmolecule expert Kim Shepard led a discussion highlighting findings from a study on the local treatment of #nsclc by dry powder inhaler. Learn more about the outcomes and potential benefits here: www.lonza.com
#weworkasone -
Lonza
@LonzaGroup
On March 17, join us and @CALifeSciences for ‘Bio on the Bay’. We are excited to host this event to discuss the latest advancements in life sciences and meet members of the life sciences community. #smallmolecules
Register here: www.eventbrite.com/e/bio-on-the-bay-317-tickets-262215953977 -
Lonza
@LonzaGroup
We expanded our #smallmolecule API labs in our Nansha, China site to increase our early-phase HPAPI manufacturing capabilities. This is part of our investments to our mid-scale manufacturing capacity at the Nansha, China site.
Read more: www.lonza.com/news/2022-03-08-14-00 -
Lonza
@LonzaGroup
Interested in learning more about the benefits of integrating drug substance to drug manufacturing?
Hear from our #smallmolecule expert on how to address drug delivery challenges presented by solubility: www.lonza.com
#weworkasone -
Lonza
@LonzaGroup
As demand for #hpapis increases, our #smallmolecule expert Christian Dowdeswell spoke with @CRTmagazine about how companies can improve their containment strategies and work with a partner to help increase their capacity. Read more here: content.yudu.com/web/fiqy/0A3zgsj/CTFeb22/html/index.html…
-
Lonza
@LonzaGroup
Did you miss out on our #smallmolecule expert’s presentation at the #hpapi Virtual Summit?
Hear about a number of tactics on how to design an effective #hpapi plant here: www.lonza.com
#weworkasone -
Lonza
@LonzaGroup
Hear from our #smallmolecule expert, David Lyon, on 23 February, where he will share his insights on how a variety of strategies and programs designs can help address solubility challenges in current drug development pipelines.
Register here: event.on24.com/eventRegistration/unavailable?&eventid=361… -
Lonza
@LonzaGroup
Missed out on our Solid Form Screening webinar?
Our #smallmolecule expert covered a number of tactics on how to select effective and commercially viable formulations at early stages of the drug development cycle:www.lonza.com/knowledge-center/smallmolecules/w/sfs-formu…
#weworkasone -
Lonza
@LonzaGroup
Hear from our #smallmolecule expert on February 11 at our webinar with Outsourced Pharma to learn more about solid form screening on accelerated approval timelines. Register here: event.on24.com/wcc/r/3575296/36ACF81A65A3B47B59DC1607A57B…
#weworkasone -
Lonza
@LonzaGroup
We have just announced our collaboration with HaemaLogiX to manufacture drug substance for KappaMab, a monoclonal antibody treatment for multiple myeloma.
Learn more: www.lonza.com/news/2022-01-27-22-30 -
Lonza
@LonzaGroup
Lonza’s Outlook for 2022 remains strong, with a continuing focus on operational excellence and execution of growth projects, we expect to deliver an improved CORE EBITDA margin in line with 2024 Mid-Term Guidance. www.lonza.com/news/2022-01-26-07-01 #lonzafullyear2021
-
Lonza
@LonzaGroup
In 2021, CAPEX reached 24% of sales, supporting our long-term plan to deliver attractive margins through de-risked growth investments and a selective approach to bolt-on acquisitions. www.lonza.com/news/2022-01-26-07-01 #lonzafullyear2021
-
Lonza
@LonzaGroup
Lonza delivers strong 2021 financial results with CHF 5.4 billion sales and 20% CER sales growth. www.lonza.com/news/2022-01-26-07-01 #lonzafullyear2021
-
Lonza
@LonzaGroup
Our Head of R&D for #smallmolecule API Division Jason Zhang spoke with Outsourcing Pharma about how our dedicated manufacturing line in Nansha, China ensures our integrated strategy and remains timely for our customers. Read more here: www.outsourcing-pharma.com/Article/2022/01/03/Integrated-…
-
Lonza
@LonzaGroup
Lonza Drug Product Services is participating in the RealHOPE project, which aims to measure events during drug handling that can destabilize protein-based therapeutics.
Learn more: www.lonza.com/news/2022-01-19-14-00 -
Lonza
@LonzaGroup
We have expanded our collaboration with Joint Venture partners Forbion and BioGeneration Ventures to support the development and manufacture of small molecules therapies.
Learn more: www.lonza.com/news/2022-01-18-14-00 -
Lonza
@LonzaGroup
Today we announced the launch of our new bYlok™ technology, for engineering specific antibodies to streamline future clinical manufacturing.
Learn more: www.lonza.com/news/2022-01-18-09-00 -
Lonza
@LonzaGroup
Today, we announced a collaboration with Agilent to integrate new analytical technologies into our Cocoon® Platform. The collaboration aims to develop and integrate analytical technologies to the patient-scale manufacturing of Cocoon®.
Learn more: www.lonza.com/news/2021-12-15-14-00 -
Lonza
@LonzaGroup
Meet Jakob Bonde, Head of Regulatory Affairs, Small Molecules. Learn more about his work in regulatory compliance for our global customers: www.lonza.com
#meettheexperts #weworkasone -
Lonza
@LonzaGroup
We have entered into a research license agreement with Doer Biologics to develop its multi-specific biotherapeutics leveraging Lonza’s XS® Pichia Expression System. Read more under www.lonza.com/news/2021-12-08-14-00
-
Lonza
@LonzaGroup
Searching for your next podcast? Our ‘A View On’ podcast, hosted by @DrHestericova, was ranked in @Labiotech_eu ’s Top 10 #biotech podcasts of 2022. Read the full list here and subscribe for new episodes to hear from industry leaders: www.labiotech.eu/best-biotech/biotech-podcasts-science-bu…
-
Lonza
@LonzaGroup
Hear from our #smallmolecule experts on December 2nd at our webinar with Outsourced Pharma to learn more about handling antibody drug conjugates (ADCs). Register here: event.on24.com/wcc/r/3515462/8897215683FA0DB75AF2DF422D1F…
-
Lonza
@LonzaGroup
Today we announced a framework agreement with Bioqube Ventures for the future development and manufacture of biologics and small molecules for its portfolio companies.
Learn more: www.lonza.com/news/2021-11-30-14-00 -
Lonza
@LonzaGroup
Listen to our new A View On episode with Eran Elinav from the Weizmann Institute of Science and learn about how we can utilize the microbiome to develop personalized medicines.
www.youtube.com/watch?v=r_nBz51f30Q -
Lonza
@LonzaGroup
Our Head of Microbial Business Shiva Khalafpour spoke with @BioPharmReport about the increasing demand for microbial drug products and how our recent expansion in our Visp site supports our partners bring their therapies to the market.
Read more: www.biopharma-reporter.com/Article/2021/11/18/Industry-se… -
Lonza
@LonzaGroup
Meet Deanna Mudie, a Principal Scientist in R&D, focused on bioavailability enhancement. Learn more about her work: www.lonza.com
#meettheexperts #weworkasone
Lonza
@LonzaGroup
Interested in hearing from more experts? Follow to receive real time updates on our next release for our “Meet the Experts” video series and learn how their findings are creating #weworkasone. www.lonza.com
#meettheexperts -
Lonza
@LonzaGroup
We have signed a manufacturing agreement with BlueJay Therapeutics, to produce one of their lead mAb candidates. The mAb targets chronic HBV, which currently has a low cure rate, highlighting the need for innovative therapies.
Read more: www.lonza.com/news/2021-11-17-14-00 -
Lonza
@LonzaGroup
Today we announced the expansion of our microbial development laboratories at our Visp (CH) site, by 50%. The expansion will support new projects in Lonza's existing manufacturing assets, and add new high throughput equipment and automation.
Read more: www.lonza.com/news/2021-11-16-14-00 -
Lonza
@LonzaGroup
We are continuing to strengthen our position as a leading global CDMO in the field of extracellular vesicle (EV) bioprocessing with the acquisition of the service unit from @exosomics_dx, in Siena, Italy. pharma.lonza.com/technologies-products/exosomes
-
Lonza
@LonzaGroup
We have acquired an exosome manufacturing site from @codiakbio, in Lexington, Massachusetts (US), and established a long-term strategic collaboration focused on jointly developing our exosome manufacturing and characterization technologies. pharma.lonza.com/technologies-products/exosomes
-
Lonza
@LonzaGroup
Learn from our #smallmolecule experts on our offerings in #chromatography and allied downstream technologies. Tune in: www.lonza.com
#hpapi -
Lonza
@LonzaGroup
Missed out on AAPS #pharmsci360? Our #smallmolecule experts covered a number of innovative capabilities from stem cell preservation to amorphous solid dispersions on poorly water-soluble oncology drugs:
www.lonza.com -
Lonza
@LonzaGroup
Our #smallmolecule and #biologics experts will be attending #cphiworldwide on 9-11 November, 2021 in Milan, Italy. Visit us at our booth (stand 4G20) or schedule a meeting here: www.lonza.com
-
Lonza
@LonzaGroup
Hear from our #smallmolecule experts at
@AAPSComms #pharmsci360 to learn more about our capabilities in #drugdevelopment, particle engineered intermediates, and drug substances. Learn more about our sessions here: www.lonza.com -
Lonza
@LonzaGroup
At today’s 2021 Capital Markets Day, our CEO Pierre-Alain Ruffieux will outline Lonza’s strategic priorities and innovation highlights at a Group and divisional level. www.lonza.com/news/2021-10-12-07-03
-
Lonza
@LonzaGroup
As part of our continued investment in Asia, we are expanding the mammalian development services at our Singapore facility. We will invest in the latest technology and double our footprint with a 1,800m² laboratory at Singapore Science Park.
Learn more: www.lonza.com/news/2021-10-07-14-01 -
Lonza reposted
IMD
@IMD_Bschool
CEO of @LonzaGroup Pierre-Alain Ruffieux shares with IMD President Jean-François Manzoni how COVID-19 and a partnership with @moderna_tx threw the little known biotech company into the public eye: www.imd.org/ibyimd/videos/ceo-dialogue-series/thrust-into…
#ibyimd #imdimpact -
Lonza
@LonzaGroup
Tune in to an on-demand webinar from our #smallmolecules expert Deanna on the use of biorelevant dissolution media to accelerate #drugdevelopment: www.lonza.com
-
Lonza
@LonzaGroup
Hear how our #pharma & #biotech experts can optimize #hpapi #smallmolecule development from early phases to commercialization.
Register for the webinar here: event.on24.com/eventRegistration/EventLobbyServlet?target… -
Lonza
@LonzaGroup
We are supporting @AllarityTx with the development and manufacturing of dovitinib, a renal cell carcinoma candidate with a possible use in other indications, such as liver cancer, breast cancer and various solid tumors. www.lonza.com/news/2021-09-23-10-01
-
Lonza
@LonzaGroup
#pharma and #biotech developers use biorelevant dissolution media to predict in vitro performance for solid oral products. Join a #smallmolecule expert for a presentation on choosing the best predictive media to accelerate development: event.on24.com/wcc/r/3310740/CE79085A8B437FDBBD32A42D4672…
-
Lonza
@LonzaGroup
We are expanding our drug product manufacturing network in Switzerland. This will include the installation of a new aseptic fill and finish line in Stein and the expansion of Drug Product Services in Basel (CH). www.lonza.com/news/2021-09-22-14-00
-
Lonza
@LonzaGroup
As one of the most complex supply chains in #pharma, streamlining the development of ADCs under one roof is essential to deliver new, innovative drugs to market and patients sooner. Learn more in this @CHEManager_EU article: chemanager-online.com/en/news/managing-supply-for-complex…
-
Lonza
@LonzaGroup
The first patient has been dosed with Triumvira's TAC-T cell breast cancer treatment manufactured with Lonza's Cocoon® Platform. www.lonza.com/news/2021-09-21-14-00
-
Lonza
@LonzaGroup
Watch a presentation from Lonza experts on engineering approaches to advance micro-dosing APIs from first-in-human trials to commercialization.
www.lonza.com -
Lonza
@LonzaGroup
We are pleased to announce that Philippe Deecke will take the role of Chief Financial Officer (CFO) for Lonza Group, commencing on 1 December 2021. Philippe will also become a member of the Lonza Executive Committee. www.lonza.com/news/2021-08-26-07-02
-
Lonza
@LonzaGroup
Scaling up manufacturing for micro-dosing APIs can create challenges for #biotech and #pharma developers. Register for a webinar with #lonza experts to learn about technology selection and development approaches to advance to commercialization.
event.on24.com/eventRegistration/unavailable?&eventid=334… -
Lonza
@LonzaGroup
We are establishing drug product manufacturing services at our site in Guangzhou, China. The installation of a new fill and finish line will significantly expand the sites capabilities for the benefit of our customers in China and around the globe.
www.lonza.com/news/2021-08-23-07-00 -
Lonza
@LonzaGroup
We are pleased to share that multiple patients have been successfully dosed with a CD19 autologous CAR-T cell therapy using our Cocoon® automated manufacturing Platform at Sheba Medical Center, Israel.
Learn more: www.lonza.com/news/2021-08-12-15-00 -
Lonza
@LonzaGroup
Watch virtual presentations from Lonza experts at @CPhI_Conference North America. Learn about #smallmolecule devepment approaches used to advance products for #pharma and #biotech customers.
www.lonza.com -
Lonza
@LonzaGroup
Efficient development of #smallmolecule therapies depends on tools to predict performance in patients. Read this article from a Lonza expert on the use of biorelevant dissolution media to accelerate #drugdevelopment. www.epmmagazine.com/pharmaceutical-industry-insights/phar…
-
Lonza
@LonzaGroup
Monoclonal antibodies can treat #lungcancer locally via inhaled dry-powder formulations. Watch this replay of an expert presentation on engineering approaches to enable lung delivery of mAbs.
www.lonza.com -
Lonza
@LonzaGroup
Watch virtual presentations from Lonza experts at @CPhI_Conference North America. Learn about #smallmolecule devepment approaches used to advance products for #pharma and #biotech customers.
www.lonza.com -
Lonza
@LonzaGroup
We have maintained a strong performance in H1 with sales of CHF 2.5 billion, sales growth of 14.7% and CHF 847 million CORE EBITDA, resulting in a margin of 33.3%. www.lonza.com/news/2021-07-23-07-02 #financialresults #ahealthierworld
-
Lonza
@LonzaGroup
With a common goal of improving drug discovery accuracy and efficiency, Lonza will supply a selection of cells to be prequalified for use in CN Bio’s innovative PhysioMimixTM Organ-On-a-Chip range.
www.lonza.com/news/2021-07-19-15-00 -
Lonza
@LonzaGroup
Monoclonal antibodies can treat #lungcancer locally via inhaled dry-powder formulations. Watch this replay of an expert presentation on engineering approaches to enable lung delivery of mAbs.
www.lonza.com -
Lonza
@LonzaGroup
We have entered into an agreement to supply monoclonal antibodies for the manufacture of a customer’s ADC at our Ibex® Solutions biopark in Visp. ADCs are highly potent and complex molecules that offer an innovative therapy option to treat cancer.
www.lonza.com/news/2021-07-16-07-01 -
Lonza
@LonzaGroup
Inhaled formulations of monoclonal antibodies can enable targeted treatment of lung diseases, including #lungcancer, while reducing side effects. Register for a webinar to learn about engineering approaches for dry-powder inhaled formulations for mAbs.
www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… -
Lonza
@LonzaGroup
As drug development networks become increasingly global, project management has become more important for small #biotech firms. Find out how effective #cdmos can help manage complex projects while speeding development timelines.
www.outsourcedpharma.com/doc/project-management-to-meet-t… -
Lonza
@LonzaGroup
Our Lonza family is united by a common purpose - to enable #ahealthierworld. This purpose is our reason for being and what motivates us to succeed, every single day. Together, we make #ameaningfuldifference. Watch our new company video:
-
Lonza
@LonzaGroup
We have completed the divestment of our former Specialty Ingredients business and operations to @BainCapital and Cinven for an enterprise value of CHF 4.2 billion. www.lonza.com/news/2021-07-02-07-00
-
Lonza
@LonzaGroup
For #biotech companies, a #cdmo partner should provide a working model that meets each customer’s specific needs. Read a case study on how we partner with one customer, Aurinia, providing flexible manufacturing to help advance innovative treatments.
cen.acs.org/business/outsourcing/big-pharma-estetrol-vocl… -
Lonza
@LonzaGroup
AI can help inform #biotech companies’ manufacturing decisions. Lonza experts Stephan Rosenberger and David Vodak discuss how digital innovation may bring treatments to patients sooner. Read the @pharmasalmanac article to find out more.
www.pharmasalmanac.com/articles/q-how-have-evolving-techn… -
Lonza
@LonzaGroup
Find out more about how #lonza can use cutting-edge micronisation capabilities to help advance challenging molecules. Use the link below to set up a meeting with a member of the #lonza team. We look forward to meeting you!
calendly.com/d/nbbf-xbdq/meet-your-lonza-bd-micronization… -
Lonza
@LonzaGroup
We are investing over CHF 20m in GMP laboratories and mid-scale manufacturing assets at our API manufacturing center in Nansha, China - allowing us to provide a smooth transition from small-scale to large-scale manufacturing for our global customers.
www.lonza.com/news/2021-06-28-15-00 -
Lonza
@LonzaGroup
If you want to learn more about Lonza’s micronisation capabilities and how they can help advance your next molecule, you can use the link below to set up a meeting with a member of the #lonza team. Our colleagues look forward to speaking with you!
calendly.com/d/nbbf-xbdq/meet-your-lonza-bd-micronization… -
Lonza
@LonzaGroup
Watch a replay of a webinar with @FiercePharma on micronisation techniques for #hpapi drug products. Find out more about advancing #smallmolecule drugs and other products at the Lonza Knowledge Center.
www.lonza.com -
Lonza
@LonzaGroup
Advances in technology are accelerating the development and manufacture of subunit #vaccines, an established class of vaccines.
Learn more from our colleagues at #lonza about how these vaccines have a role to play in the fight against #covid19.
protect-us.mimecast.com/s/kXUhCwpAOJCANMxIVbhck -
Lonza
@LonzaGroup
For #biotech firms developing #hpapi treatments, identifying efficient manufacturing processes is essential to advancing products on accelerated timelines. Register for a presentation at the 10th HPAPI Summit and schedule a meeting with a Lonza expert.
www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… -
Lonza
@LonzaGroup
Micronisation is an effective way to advance development of many #smallmolecule formulations. Join a Lonza expert for a webinar with @FiercePharma on micronisation insights for #hpapi products.
www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… -
Lonza
@LonzaGroup
Today, we have announced the expansion of our collaboration with @moderna_tx to manufacture the drug substance for the COVID-19 Vaccine Moderna at our site in Geleen (NL). www.lonza.com/news/2021-06-02-07-02
-
Lonza
@LonzaGroup
.@BactheraAG, our joint venture with Chr. Hansen, has achieved a significant milestone by receiving manufacturing licenses for its facilities in Switzerland and Denmark. Congratulations to the entire team on this exciting step forward. More info under www.microbiometimes.com/bacthera-receives-manufacturing-l…
-
Lonza reposted
Military Makeover
@MilitaryMkover
Whether you’re interested in being on the front lines or helping behind the scenes, @LonzaGroup provides the perfect place for veterans to continue serving! 🧬
Learn more about the company and open opportunities at: www.pharma.lonza.comThis media couldn't be displayed. See it on the original post. -
Lonza
@LonzaGroup
Today we held our 2021 AGM. Due to the ongoing COVID-19 pandemic, the event was conducted without the presence of shareholders. 47,080,080 shareholders delegated their votes to the independent proxy, representing 63.22% of the share capital. www.lonza.com/investor-relations/agenda-and-events/agm
-
Lonza
@LonzaGroup
Today, we have announced significant investments of approximately CHF 850 million to expand our mammalian drug substance manufacturing facilities in Visp (CH) and Portsmouth (US). www.lonza.com/news/2021-05-06-07-02
-
Lonza
@LonzaGroup
We are excited to partner with Ankyra Therapeutics, a biotechnology company developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response, on their very first complex protein program. www.lonza.com/news/2021-05-05-15-00
-
Lonza
@LonzaGroup
Today, we have announced the expansion of our collaboration with @moderna_tx to manufacture the drug substance for the COVID-19 Vaccine with the installation of three additional drug substance manufacturing lines at our Visp (CH) site. www.lonza.com/news/2021-04-29-05-00
-
Lonza
@LonzaGroup
We have announced the construction of a new small molecule manufacturing complex for antibody-drug conjugates payload molecules at our Visp (CH) site. Learn more under:
www.lonza.com/news/2021-04-23-05-00 -
Lonza
@LonzaGroup
We are delighted to collaborate with @ImmunitasTx to advance the manufacturing process for its lead drug candidate, IMT-009, using a customized, accelerated version of Lonza's Ibex® Design program. www.lonza.com/news/2021-04-15-13-00
-
Lonza
@LonzaGroup
We are looking forward to supporting @aTyrNews as they advance their novel monoclonal antibody ATYR2810 from preclinical stages into clinical for cancer therapeutics. Click here to read the full press release: www.lonza.com/news/2021-04-14-12-00
-
Lonza
@LonzaGroup
2021 marks the 20th anniversary of our groundbreaking Nucleofector™ Technology, the industry’s leading non-viral cell transfection method, which revolutionized cell transfection. Congrats to our colleagues worldwide who have contributed to its success. www.lonza.com/news/2021-04-07-13-00
-
Lonza
@LonzaGroup
#phages invade clinically relevant bacteria and cause them to lyse, while sparing all beneficial bacteria. Listen to our new #podcast with Jonathan Solomon of BiomX to get #aviewon phage-based therapies and their manufacturing. #pharmaceuticalindustry
-
Lonza
@LonzaGroup
We have announced a collaboration with @Pionyrimmunotx, a company developing first-in-class antibody therapeutics that increase the body’s anti-tumor immunity, to support their oncology product development. www.lonza.com/news/2021-03-29-13-00
-
Lonza
@LonzaGroup
Today we have published our 2020 Annual Report.
“We are pleased and proud of our progress in 2020, and we are confident that we can use this as a strong foundation to drive further success in the coming year,” said Pierre-Alain Ruffieux, CEO Lonza.
annualreport.lonza.com/2020/ -
Lonza
@LonzaGroup
We've expanded our previously-announced manufacturing agreement with @AltimmuneInc. We will commission a dedicated manufacturing suite for potential late-stage clinical and commercial production of AdCOVID, Altimmune’s COVID-19 vaccine candidate www.lonza.com/news/2021-03-12-06-00
-
Lonza reposted
Vineti
@vinetiworks
In the latest episode of @LonzaGroup's A View On podcast, Vineti's Co-Founder & CEO, Amy DuRoss, discusses the challenges facing "just-in-time" manufacturing & delivery of #personalizedtherapies, plus the solutions her digital startup provides.
Listen. go.pardot.com/l/834493/2021-03-05/3cj753/9978 -
Lonza
@LonzaGroup
We just announced our strategic agreement with PsiVac, a UK biotechnology research and development company focused on the development of new therapeutic cancer treatments for solid tumors. www.lonza.com/news/2021-03-08-14-00
-
Lonza
@LonzaGroup
We spoke with Amy DuRoss, the CEO of @Vineti, about how their software solutions for advanced therapy supply chain orchestration can help to manage the complex manufacturing challenges of personalized therapies. Access the podcast episode here: www.youtube.com/watch?v=rA-TA2nOvyw #aviewon
-
Lonza
@LonzaGroup
The sale of the Specialty Ingredients business will allow Lonza to focus on its position as a leading partner to the healthcare industry www.lonza.com/news/2021-02-08-20-12
-
Lonza
@LonzaGroup
The divestment of our Specialty Ingredients business to Bain Capital and Cinven will allow the full potential of the business to be unlocked www.lonza.com/news/2021-02-08-20-12
-
Lonza
@LonzaGroup
We are pleased to confirm we have signed an agreement to divest our Specialty Ingredients business to @BainCapital and Cinven www.lonza.com/news/2021-02-08-20-12
-
Lonza
@LonzaGroup
Today we have reported strong 2020 financial results, which demonstrate the exceptional commitment of our employees and the resilience of our business during a year of unprecedented change. www.lonza.com/news/2021-01-27-06-00 #lonzafullyear2020
-
Lonza
@LonzaGroup
#lonzafullyear2020 results mainly reflect Pharma Biotech & Nutrition performance with 12.2% CER sales growth and 32.1% CORE EBITDA margin. www.lonza.com/news/2021-01-27-06-00
-
Lonza
@LonzaGroup
Lonza reports strong 2020 performance, driven by sales growth in pharma and biotech business with CHF 4.5 billion sales, 12.0% CER sales growth, and CHF 1.4 billion CORE EBITDA, resulting in a 31.2% margin www.lonza.com/news/2021-01-27-06-00
#lonzafullyear2020 -
Lonza reposted
WBAL-TV 11 Baltimore
@wbaltv11
The Maryland horseshoe crab is playing a vital role in ensuring the coronavirus vaccine is clean and safe to use. www.wbaltv.com/article/maryland-horseshoe-crab-covid-19-v…
-
Lonza
@LonzaGroup
With the completion of another KUBio installation at our new Guangzhou Biopark (CN), we have reached a significant milestone. Thanks to the @Cytiva team for your great agility and speed in delivering this important site.
Cytiva
@Cytiva
Today we celebrate the successful completion of another #kubio at our partner, @LonzaGroup's new Guangzhou Biopark in China, reaching a significant milestone to respond to the great demand of antibody development services and manufacturing, in China and the rest of the world.
-
Lonza
@LonzaGroup
We have entered a new collaboration with @Capricor Therapeutics, Inc. for the development of CAP-1002, its cell therapy candidate, for the treatment of Duchenne Muscular Dystrophy (DMD) and complications arising from COVID-19.
-
Lonza
@LonzaGroup
Swiss Federal Councillor @alain_berset, Head of the Department of Home Affairs and State Councillors @C_Darbellay and Esther Waeber-Kalbermatten, visited our facility in Visp (CH) to gain an on-site impression of the active ingredient production for the COVID-19 Vaccine Moderna.
Alain Berset
@alain_berset
Austausch mit der Regierung @CantonduValais und Besuch bei @LonzaPB, Produzentin des @moderna_tx-Impfstoffs, dessen Zulassung läuft. Wir haben auf die richtigen Impfstoffe gesetzt, sind auf Kurs: Im Sommer sind alle geimpft, die wollen – es sind erfreulich viele. #coronainfoch
-
Lonza
@LonzaGroup
The COVID-19 Vaccine Moderna has received the green light from Swissmedic for use in Switzerland.
Our congrats to @moderna_tx on another key milestone and we’re proud to be supporting the efforts to bring a vaccine to the world.
Swissmedic
@Swissmedic_
Swissmedic hat heute den zweiten Covid-19 Impfstoff zugelassen.
Nach sorgfältiger Prüfung aller eingereichten Daten zur Sicherheit, Wirksamkeit und Qualität wurde heute der Impfstoff von Moderna in der Schweiz befristet zugelassen.
di-ri.co/wu9ep -
Lonza
@LonzaGroup
We are adding two production suites to the existing conjugation facility in Visp, providing development & manufacturing infrastructure for clinical & commercial supply. www.lonza.com/news/2020-12-21-06-00
-
Lonza
@LonzaGroup
#exosomes, extracellular vesicles produced by eukaryotic cells, have great potential for treating #diseases or improve #diagnostic technologies. Our new #podcast with Lonza's CSO, Uwe Gottschalk, offers an insight into the fascinating world of exosomes. youtu.be/4MeVPYAz7Xc
-
Lonza reposted
UoNBiosciences
@UoNBiosciences
Lonza Biotechnology - For Best Academic Achievement on the Course Awarded to Jose Velazquez Gomez
Runner up: Eman Farrukh
@bora_nagamani @NatalieAMack
#weareuon #uonbiosci #classof2020 -
Lonza
@LonzaGroup
We have expanded our Ibex® Dedicate facility as part of a new long-term strategic collaboration with a global biopharma company adding two new bioconjugation suits for the commercialization of ADCs www.lonza.com/news/2020-12-02-06-00
-
Lonza
@LonzaGroup
New podcast on the microbiome: Lukas Schüpbach, CEO of Bacthera, and Gemma Henderson, Project and Portfolio Management, share insights into the manufacturing of live biotherapeutics-based therapies: lonza.com/news-and-media/a-view-on-podcast
#lonza #aviewon #microbiome #pharmaceuticalindustry -
Lonza
@LonzaGroup
Today, we announced that we'll be entering into a partnership with @BeTheMatch to expand our Vein-to-Vein #cgt supply chain network, integrating services in our respective offerings to provide a seamless offering to customers. #nexttogether #trailblazers www.lonza.com/news/2020-11-19-14-00
-
Lonza
@LonzaGroup
We congratulate @moderna_tx on its successful phase 3 clinical trial data with a vaccine efficacy of 94.5%, which represents a significant scientific achievement and serves as a testament to Moderna’s commitment to controlling the #covid19 pandemic investors.modernatx.com/news-releases/news-release-detail…
-
Lonza
@LonzaGroup
Today, we announced an agreement to manufacture Altimmune Inc.'s AdCOVID™, a single-dose intranasal vaccine candidate for #covid19. As a strategic manufacturing partner, we will help to ensure commercial readiness to supply vaccines in 2021. www.lonza.com/news/2020-11-10-06-00
-
Lonza reposted
Embassy of Switzerland in the USA
@SwissEmbassyUSA
Stacey Hanna, General Counsel, Global Compliance and Ethics at #swiss chemicals and #biotechnology company @LonzaGroup shares how they've been able to deploy their resources and respond to the #covid19 crisis quickly and efficiently. @SwissAmbUSA www.youtube.com/watch?v=5Yqql1v3LDw
-
Lonza
@LonzaGroup
Today, we welcome Pierre-Alain Ruffieux as our new Chief Executive Officer. We would like to thank Albert Baehny for his leadership over the last year in the role of CEO ad interim, and wish Pierre-Alain much success in his new role.
www.lonza.com/news/2020-11-02-06-00 -
Lonza
@LonzaGroup
Today, #lonza announced an agreement to manufacture @AstraZeneca's potential #covid-19 treatment AZD7442, a combination of two long-acting #antibodies currently in Phase I clinical studies. Operations are expected to start in H1 2021. www.lonza.com/news/2020-10-30-06-00
-
Lonza
@LonzaGroup
Live from today's Investor Update in Zurich, CH, with Albert M. Baehny, Chairman and CEO ad interim, and Pierre-Alain Ruffieux, commencing his new role as CEO of Lonza Group in November 2020. More info under: www.lonza.com/news/2020-10-15-05-00
-
Lonza
@LonzaGroup
At today’s Investor Update we set out the new structural blueprint for our LPBN segment. More info under: www.lonza.com/news/2020-10-15-05-00 Pierre-Alain Ruffieux also attended the presentation in his capacity as future CEO of Lonza Group commencing his new role in Nov 2020. He commented:
-
Lonza
@LonzaGroup
Today, we present our Investor Update in Zurich, Switzerland, where Albert M. Baehny, Chairman and CEO ad interim, shares the blueprint for our future organization including the new company structure, updated financial reporting, culture and future plans. www.lonza.com/news/2020-10-15-05-00
-
Lonza
@LonzaGroup
Join us next Thursday for a new podcast episode featuring Andrè Choulika, CEO of Cellectis, who will offer "A view on" gene editing and its applications.
#aviewon #cellectis #geneediting #genomeediting #nucleases #crispr #talen -
Lonza
@LonzaGroup
Thank you to the Frederick County Office of Economic Development for nominating our Lonza site in Walkersville, MD as an RMI Champion of Maryland Manufacturing.
-
Lonza reposted
Microbial Control Executive Council
@antimicrobials
To break the chain of #sarscov2 infection, #disinfectants are a key factor to keep hands, hard surfaces as well as devices germ free, says #mcec member, Ernesto Lippert from @LonzaGroup, @chemicalwatch
-
Lonza
@LonzaGroup
#lonza announced its partnership with @humanigen gen to expand the manufacturing capacity of Humanigen's #covid-19 therapeutic candidate, lenzilumab. Together, the companies are working to combat this global health crisis. www.lonza.com/news/2020-09-15-05-00
-
Lonza
@LonzaGroup
#lonza announced that the first patient has been treated at Sheba Medical Center with a CD19 CAR-T cell immunotherapy manufactured using Lonza’s Cocoon® Platform. This approach will make lifesaving therapies available to many more patients in need. lonza.com/news/2020-09-08-05-00
-
Lonza reposted
The Market NZZ
@TheMarket_CH
Albert Baehny, Chairman and CEO of @LonzaGroup: «We are quite optimistic that the #vaccine of Moderna will work»
$LONN $MRNA #covid19 @moderna_tx
themarket.ch/interview/lonza-we-are-at-the-right-place-at… -
Lonza
@LonzaGroup
#lonza announced a collaboration with Isoplexis to provide Lonza’s Cocoon® Platform with high quality biological analytics. With Isoplexis' IsoLight® technology, Lonza's cell therapy manufacturing will be more precise and effective. lonza.com/news/2020-08-20-13-00
-
Lonza
@LonzaGroup
Cannabinoids are a novel treatment option for a range of conditions, including autoimmune and other immune-related diseases. In the new #aviewon episode, @DrHestericova speaks with Alain Rolland of Emerald Health Pharmaceuticals about #cannabinoid science www.lonza.com/news-and-media/a-view-on-podcast
-
Lonza
@LonzaGroup
Our NUGEN® NR Wipes have been nominated for this year’s World Of Wipes® Innovation Award #wipes20 #wipescon. The WOW Conf will be held from Aug 25-27th, all virtual, the winner to be announced on the final day
#keepingourworldhealthy #disinfection #innovation #norinse #nrwipes -
Lonza
@LonzaGroup
This week our Williamsport facility was proud to be recognized by @RepFredKeller, for all its work to control and contain the spread of #covid19. We are resolved to continue to play our part in the fight against the coronavirus, as a supplier of essential products and services.
Congressman Fred Keller
@RepFredKeller
Great tour of Lonza’s Williamsport facility today. Lonza is a major producer of disinfectant products that have been vital for our first responders, community, and country during COVID-19. Thank you for the tour!
-
Lonza
@LonzaGroup
Join us next Thursday to listen to a new episode of #aviewon #podcast. We will be talking to Alain Rolland, the COO of Emerald Health Pharmaceuticals, about cannabinoid-based medicines www.lonza.com/a-view-on
#emerald #cannabinoids #pharmaceuticalindustry #cannabidiol -
Lonza
@LonzaGroup
#lonza announced an expansion of our microbial manufacturing facilities in Visp, CH housing Lonza’s Ibex™ Solutions. Focused on speed to market, the expansion will support customers, like @Servier, from clinical supply to commercial production. lonza.com/news/2020-08-04-05-00
-
Lonza
@LonzaGroup
#lonza continues a long-term partnership with @KodiakSciences to commercially manufacture KSI-301, an ABC for retinal diseases. Lonza’s leadership in bioconjugation and complex supply chains will help Kodiak effectively scale up.
-
Lonza
@LonzaGroup
Key message from Albert M. Baehny, Chairman and CEO ad interim, on our #lonzahalfyear2020 results:
lonza.com/news/2020-07-24-05-00 -
Lonza
@LonzaGroup
LSI carve-out is nearing completion, with some activities left to undertake. In this context, Lonza has decided to divest the business through a sale process, to be initiated in H2. #lonzahalfyear2020 lonza.com/news/2020-07-24-05-00
-
Lonza
@LonzaGroup
Growth driven by LPBN segment which delivered 10.8% sales growth and CORE EBITDA margin of 34.1%. #lonzahalfyear2020 lonza.com/news/2020-07-24-05-00
-
Lonza
@LonzaGroup
#lonzahalfyear2020 Landmark ten-year collaboration with @moderna_tx on their mRNA platform. The current focus is to manufacture an mRNA-based vaccine (mRNA-1273) for the novel coronavirus lonza.com/news/2020-07-24-05-00
-
Lonza
@LonzaGroup
Strong operational performance maintained during COVID-19; sites remained open and protection of employees remained a top priority #lonzahalfyear2020 lonza.com/news/2020-07-24-05-00
-
Lonza
@LonzaGroup
Today we announced our H1 2020 results with strong Group sales growth of 7.7% and a resilient CORE EBITDA margin of 29.1%. The results reflect our robustness to the challenges and uncertainties arising from the COVID-19 pandemic in H1. #lonzahalfyear2020 lonza.com/news/2020-07-24-05-00
-
Lonza
@LonzaGroup
Listen to the new episode of #aviewon #podcast where Lonza's @DrHestericova speaks to Silviu Itescu, the CEO of @Mesoblast, about using mesenchymal #stemcells to treat severe cases of #covid19.
Access the podcast episode here: lonza.com/news-and-media/a-view-on-podcast -
Lonza reposted
RegMedNet
@RegMedNet
Manufacturing challenges and enabling current and emerging applications in #ipsc-based therapies. Read more in this free commentary from the experts at @Lonzagroup. #rmnipscexpansion www.regmednet.com/lonza-2020-q3spotlight-human-induced-pl…
-
Lonza
@LonzaGroup
Join us next Monday for a new episode of #aviewon #podcast. We will talk with Siviu Itescu, the CEO of @Mesoblast, about the potential of mesenchymal stem cells to treat COVID-19 respiratory distress syndrome. www.lonza.com/news-and-media/a-view-on-podcast #covid19 #stemcells #pharmaceuticallindustry
-
Lonza
@LonzaGroup
Can you reduce attrition rates and cost during the development of biotherapeutics? Discover more in our webninar De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression & Genetic Characterisation Tools #biotechnology #webinar pages.questexnetwork.com/Lonza-070820-Registration.html?s…
-
Lonza
@LonzaGroup
We are excited to announce the second episode of #aviewon #podcast about using cell-penetrating peptides for #cancer treatment. Listen to Lonza's @DrHestericova speaking with Per Hellsund and Vishwas Paralkar of @Cybrexa
Access the podcast episode here: lonza.com/news-and-media/a-view-on-podcast -
Lonza
@LonzaGroup
The next episode of our #aviewon podcast airs next Monday!
Join us and hear more about cell-penetrating peptides. Our guests are Per Hellsund, and Vishwas Paralkar from #cybrexa Therapeutics.
www.lonza.com/news-and-media/a-view-on-podcast
#peptides #cancer #oncology -
Lonza reposted
Capsugel®
@CapsugelNews
The patient-centric design of DBcaps® over-encapsulation capsules makes them easier to swallow, improving patient compliance. Download the over-encapsulation guide to learn more. #patient-centric www.capsugel.com/knowledge-center/clinical-trials-over-en…
-
Lonza reposted
Tufts Launchpad | BioLabs
@BioLabsBoston
#congratulations to @CELLINK3D on collaborating with Lonza to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to advance complete 3D cell culture workflows. Exciting news for #bioscience #innovation and #3dprinting
www.cellink.com/lonza-and-cellink-join-forces-to-offer-co… -
Lonza
@LonzaGroup
The Board of Lonza announced today that Pierre-Alain Ruffieux has been appointed Chief Executive Officer effective 1 November 2020. Read more under: lonza.com/news/2020-06-05-05-00
-
Lonza
@LonzaGroup
The first episode of "A View On" #podcast is live! Listen to the conversation between @DrHestericova and Ricky Solorzano, the CEO of @Allevi3D about the current state and future of bioprinting.
Listen to the episode here: lonza.com/a-view-on
#lonza #aviewon #bioprinting -
Lonza
@LonzaGroup
Next Tuesday we are launching our new #lonza #podcast called "A View On".
Join us and hear more about the science, challenges, and future of 3D bioprinting. Our special guest this month is Ricky Solorzano, the co-founder and CEO of @Allevi3D
#aviewon #bioprinting #3dbioprinting -
Lonza
@LonzaGroup
We are excited to announce our #podcast hosted by @DrHestericova "A View On" is a series of short conversations with industry leaders discussing new trends in pharma and #biotechnology. First episode airs on June 2nd on www.lonza.com/a-view-on
#aviewon #ameaningfuldifference -
Lonza
@LonzaGroup
Pierre Catignol, Site Head at Lonza Portsmouth, will take part in a panel on Wednesday night: What Comes Next? Strategies for COVID-19 Vaccine Development. Register now for the webinar hosted by @BioCentury go.biocentury.com/WB2020-05BioKatalystWebinar052720_Webin…
-
Lonza
@LonzaGroup
Charles Christy discussed the advancements in cell culture production for antibody treatments for #covid19, and how #lonza is monitoring for supply chain disruptions in @nresearchnews #nexttogether go.nature.com/36esvBI
-
Lonza
@LonzaGroup
Lonza is working hard to set up manufacturing suites at our facilities in the U.S. and CH for the production of Moderna’s mRNA vaccine (mRNA-1273) against the coronavirus. We intend to manufacture the first batches of mRNA-1273 at Lonza U.S. in July 2020.
Moderna
@moderna_tx
We just announced positive interim Phase 1 data for our mRNA vaccine (mRNA-1273) against novel coronavirus. Read more: investors.modernatx.com/news-releases/news-release-detail…
-
Lonza
@LonzaGroup
A very warm welcome to our new Chief Human Resources Officer (CHRO) and member of our Executive Committee Caroline Barth, who joins Lonza today.
#ameaningfuldifference #wearelonza -
Lonza
@LonzaGroup
#lonza and @moderna_tx announce a long-term collaboration to address the #covid19 pandemic. Lonza will manufacture Moderna's mRNA #vaccine with first batches expected to be manufactured in July. Read more: www.lonza.com/news/2020-05-01-04-50
-
Lonza
@LonzaGroup
Lonza AGM News: Shareholders re-elected all existing members of the Board of Directors who stood for re-election and elected Dorothée Deuring and Moncef Slaoui as new members of the Board of Directors lonza.com/news/2020-04-28-12-10
-
Lonza
@LonzaGroup
Lonza announces results of the 2020 Annual General Meeting – all motions proposed by board of directors accepted lonza.com/news/2020-04-28-12-10
-
Lonza reposted
RegMedNet
@RegMedNet
How could allogeneic sources advance #cart #celltherapy? Read the latest article from @LonzaGroup as part of our #rmnspotlight to find out. #rmnallogeneiccart
www.regmednet.com/challenges-and-opportunities-for-alloge… -
Lonza
@LonzaGroup
Lonza Q1 2020 news: The business retains a strong level of liquidity and continues as planned with key strategic growth projects and long-term investments; the carve-out of LSI remains on track. lonza.com/news/2020-04-17-05-00
-
Lonza
@LonzaGroup
Today we announced our Q1 2020 update: As an essential supplier of products, services and solutions, Lonza’s facilities largely remain operational, with a small number of minor disruptions caused by the #covid-19 pandemic. Click here to read more: lonza.com/news/2020-04-17-05-00
-
Lonza
@LonzaGroup
Lonza Q1 2020 performance update: LPBN net sales increased by 8.3% quarter-on-quarter CER, reaching CHF1.2 billion. LSI net sales increased by 3.8% quarter-on-quarter CER, reaching CHF409 million. lonza.com/news/2020-04-17-05-00
-
Lonza
@LonzaGroup
We are pleased to report that we have maintained a positive performance in Q1 2020, despite the challenging economic environment and operating conditions caused by the challenges arising from #covid-19. To read the full press release, visit: lonza.com/news/2020-04-17-05-00
-
Lonza
@LonzaGroup
Q1 2020 update: #lonza Group net sales reached CHF1.6 billion in Q1, up 7.4% quarter-on-quarter in constant exchange rate (CER). Read the full press release: lonza.com/news/2020-04-17-05-00
-
Lonza
@LonzaGroup
Lonza reports solid Q1 2020 performance, with segments continuing to deliveressential services for pharma and disinfection: lonza.com/news/2020-04-17-05-00
-
Lonza
@LonzaGroup
Lonza Specialty Ingredients to partner with @prologventures to lead funding for
@cleanslateuv’s initial close of a new funding round of US$7 million for mobile
device hygiene solutions amidst the COVID-19 crisis.
CleanSlate UV
@cleanslateuv
NEWS: @cleanslateuv has closed a $7M Series A investment to meet surging demand for mobile device hygiene solutions amidst Covid-19 crisis.
A hospital grade, 20 second solution for sanitizing phones in healthcare, hospitality and more. #infectioncontrol
cleanslateuv.com/news/cleanslate-uv-announces-7-million-s… -
Lonza
@LonzaGroup
In @EPM_Magazine, Lonza’s Senthil Ramaswamy, Director of Cell and Gene Technologies, R&D, shares insights on how end-to-end automation, like our Cocoon™ system, can ensure the continued supply of innovative treatments. #celltherapy #innovation
-
Lonza
@LonzaGroup
SARS-CoV-2 is an enveloped virus, whose lipid membrane can be disrupted by various means. Soap, alcohol-based solutions, bleach, hydrogen peroxide, or Quats can all inactivate the virus. #covid19 #disinfection #sarscov2 #biotech #hygiene
-
Lonza
@LonzaGroup
Affinia Therapeutics has raised $60M to develop and advance #genetherapy for treating muscle and central nervous system diseases. We at #lonza are proud to have supported the new spin-out as a seed funder. www.globenewswire.com/news-release/2020/03/31/2009133/0/e…
-
Lonza
@LonzaGroup
In 2019, Lonza supported 420 life-changing medicines. Interested in learning more about market trends and our key projects in #mammalian and #microbial Technologies? Go to: annualreport.lonza.com/2019/segments/pharma-biotech-nutri…
#sustainablefuture #lonzacares -
Lonza
@LonzaGroup
How do we respond to the challenges of Covid-19?
Here’s an update from Albert M. Baehny, Lonza Chairman and CEO a.i.: lonza.com/news-and-media/coronavirus-ceo-statement -
Lonza
@LonzaGroup
Find out how #lonza is enabling point-of-care manufacturing for patient-scale #celltherapies faster, cost-effectively and reliably through our partnership with
Triumvira Immunologics, Inc. #nexttogether -
Lonza
@LonzaGroup
Lonza Chairman and CEO ad interim Albert Baehny shares an update on how our global business is responding to the challenges of COVID-19 (Coronavirus)
www.lonza.com/news-and-media/coronavirus-ceo-statement -
Lonza
@LonzaGroup
Due to the general shortage of disinfectants - especially in public institutions - Lonza Visp has now started to produce disinfectants in larger quantities for the canton of Valais. Click here to read more: www.lonza.com/news/2020-03-20-16-30 #coronavirus #covid19 #lonzavisp #disinfection
-
Lonza
@LonzaGroup
The MIT Industrial Liaison Program is dedicated to establishing technology transfer and research collaboration. We are excited to join this program and to strengthen the beneficial relationship with MIT. www.lonza.com/news/2020-03-20-14-00 #biotechnology #strongertogether #lonza
-
Lonza
@LonzaGroup
Check out our 2019 Sustainability Report published today, providing insights into our commitments and performance regarding the most relevant #sustainability topics for us and our stakeholders. Further info on: www.lonza.com/annualreport/ #lonzacares #sustainablefuture
-
Lonza
@LonzaGroup
Today, we published our 2019 Annual Report consisting of our company overview and our segments, along with personal perspectives from the leadership team. Click here to view the report: annualreport.lonza.com/2019/
-
Lonza
@LonzaGroup
We are pleased to welcome Caroline Barth as Lonza’s new Chief Human Resources Officer (CHRO) and member of our Executive Committee. Read our press release to learn more:
www.lonza.com/about-lonza/media-center/news/Tensid/2020-0…
#ameaningfuldifference #wearelonza #humanresources #careers -
Lonza
@LonzaGroup
To celebrate #internationalwomensday, we asked 5 of our coworkers 3 questions about their work-life at #lonza.
Here are the answers of Rebecca Michael, Bonita Apta, and Julia Emburey.
Visit our LinkedIn page to read the full Q&A: www.linkedin.com/company/lonza
#iwd2020 #eachforequal -
Lonza
@LonzaGroup
To celebrate #internationalwomensday, we asked 5 of our coworkers 3 questions about their work-life at #lonza.
Here are the answers of Angelica Kohlmann and Maria Löflund.
Visit our LinkedIn page to read the full Q&A: www.linkedin.com/company/lonza
#iwd2020 #eachforequal -
Lonza
@LonzaGroup
#rarediseaseday takes place on the last day of February—with February 29th as the rarest date on the calendar—to underscore the nature of rare diseases. Today, we are proud to contribute to the Rare Disease Awareness Event organized by Rocket Pharma rocketpharma.com/patients-and-caregivers/rare-disease-day…
-
Lonza
@LonzaGroup
#rarediseaseday takes place on the last day of February—with February 29th as the rarest date on the calendar—to underscore the nature of rare diseases. Today, we are proud to contribute to the Rare Disease Awareness Event organized by Rocket Pharma rocketpharma.com/patients-and-caregivers/rare-disease-day…
-
Lonza
@LonzaGroup
We are celebrating the #motherlanguageday today! #lonza is proud to have a culturally and linguistically diverse working environment. Watch our employees speak their mother language.
#languages #culturaldiversityThis media couldn't be displayed. See it on the original post. -
Lonza
@LonzaGroup
How can pharma & biotech firms commercialize #cellandgenetherapies in a more safe, robust and cost-effective manner? #lonza expert Alberto Santagostino discusses a “cubic effect” approach to optimize technical and operational performance @PharmTechGroup: www.pharmtech.com/view/using-cubic-effect-drive-cell-and-…
-
Lonza
@LonzaGroup
As #cdmos expand their services, innovator biotechs continue outsourcing their manufacturing and development needs. #lonza expert Shiva Khalafpour talks about the 2020 outsourcing trends, including biosimilars and personalized medicine in @PharmTechGroup: www.pharmtech.com/view/growth-biologics-market-inspires-o…
-
Lonza
@LonzaGroup
The #idwgs2020 is an official event aiming to promote women and girls in science. Gender stereotypes do not belong to our world. We at #lonza want to debunk the myth that girls do not like science. Anyone can become a scientist, so join us! #womeninscience #womeninstem
-
Lonza
@LonzaGroup
How can we target tumours more precisely? By using antibody-drug conjugates. This #cancer treatment uses #antibodies to deliver a highly potent drug into the cancer cell.
www.youtube.com/watch?v=KkAKgU2A6qo
#adcs #lonza #worldcancerday -
Lonza
@LonzaGroup
To acknowledge #worldcancerday, we prepared an infographic of available #cancermedicines by type. Learn more about #cancer treatments such as #cellandgene therapy, #antibodies, #smallmolecules, and more.
-
Lonza
@LonzaGroup
Lonza among top ten employers in Switzerland! One of the largest job portals in Switzerland, jobs.ch, recently published an annual evaluation of search queries. This year, Lonza made it into the top ten for the first time www.blick.ch/news/wirtschaft/flughafen-zuerich-an-der-spi…
-
Lonza
@LonzaGroup
#didyouknow that #lonza has two locations in Basel?
Apart from the HQ in the well-known "Lonza Tower", we are also based in the Stücki Park. The building hosts several office floors and laboratories in our @LonzaDPS facility.
#basel #happyfriday -
Lonza
@LonzaGroup
We're looking forward to working together with HES-SO Valais-Wallis to develop shared competencies in education and research!
hessovalais
@hessovalais
Nouveau partenariat avec @LonzaGroup. Objectif: bâtir des compétences communes dans le domaine de la formation et de la recherche. #innovation #recherche #formation #ingénierie www.hevs.ch/fr/hes-so-valais-wallis/actualites/lonza-et-l…
-
Lonza
@LonzaGroup
Our CEO a.i. Albert M. Baehny enjoyed conversations about the recent progress of drug product manufacturing at our Lonza Stücki site in Basel.
#drugproduct #lonza #biologics @LonzaDPS -
Lonza
@LonzaGroup
"Facilitating Cell Culture Growth and Protecting Protein Integrity", interview with #lonza's Nicole Wellens, Global Product Manager for BioTherapeutics Media @Tech_Networks www.technologynetworks.com/biopharma/blog/facilitating-ce…
-
Lonza
@LonzaGroup
Key message from Albert Baehny, Chairman and CEO ad interim, on our #lonzafullyear2019 results:
-
Lonza
@LonzaGroup
The carve-out of Lonza's Specialty Ingredients segment is progressing in line with plans; completion is currently expected in mid-2020. #lonzafullyear2019 www.lonza.com/about-lonza/media-center/news/Tensid/2020-0…
-
Lonza
@LonzaGroup
Lonza outlook 2020: above mid-single digit sales growth, mid-term guidance 2022 confirmed, supported by solid building blocks
#lonzafullyear2019 www.lonza.com/about-lonza/media-center/news/Tensid/2020-0… -
Lonza
@LonzaGroup
Specialty Ingredients (LSI) shows improved 17.8% CORE EBITDA margin, despite sales growth of -3.2%; carve-out progressing according to plan #lonzafullyear2019 www.lonza.com/about-lonza/media-center/news/Tensid/2020-0…
-
Lonza
@LonzaGroup
Live from the #lonzafullyear2019 press conference in Zurich (CH) Read the full press release: www.lonza.com/about-lonza/media-center/news/Tensid/2020-0…
-
Lonza
@LonzaGroup
Pharma Biotech & Nutrition (LPBN) as driver, with 11.0% sales growth and 32.9% CORE EBITDA margin #lonzafullyear2019 www.lonza.com/about-lonza/media-center/news/Tensid/2020-0…
-
Lonza
@LonzaGroup
Lonza delivers on guidance with 6.8% sales growth, CHF 5.9bn sales, and CHF 1.6bn CORE EBITDA, resulting in a 27.4% margin #lonzafullyear2019 www.lonza.com/about-lonza/media-center/news/Tensid/2020-0…
-
Lonza
@LonzaGroup
#lonza delivers strong full-year 2019 group results, with 11% pharma segment growth #lonzafullyear2019
www.lonza.com/about-lonza/media-center/news/Tensid/2020-0… -
Lonza reposted
Capsugel®
@CapsugelNews
#didyouknow There are three parameters to consider when choosing the right capsule size. Need help finding which one is best for your application? Contact us. www.capsugel.com/contact-us
-
Lonza reposted
Careers & Employability, University of Liverpool
@livunicareers
For the first time, @LonzaGroup are opening their doors for a #careers open evening!
Meet the #lonza team, take a tour of their Manchester #finance Shared Services offices and make connections over food and drinks.
Find out more & register here: careerhub.liv.ac.uk/students/events/Detail/437031 -
Lonza
@LonzaGroup
We’re starting 2020 on the right pedal stroke! Today, @BikeLeague recognized Lonza with a Bronze Award for our efforts to build a bike bike-friendly workplace for our employees. Congrats to our team in Portsmouth and keep on cycling!
-
Lonza reposted
PDA Europe
@PDA_Europe
Don’t miss the chance to meet your peers in an exclusive environment at the @LonzaGroup facility in Basel/Switzerland at the 2020 IG Meeting Packaging Science!
Sign up today!
www.pda.org/global-event-calendar/event-detail/interest-g… -
Lonza
@LonzaGroup
Indapta therapeutics and #lonza announce strategic partnership to advance a next-generation, off-the-shelf, #allogeneic immuno-oncology #therapy. www.lonza.com/about-lonza/media-center/news/Tensid/2020-0…
-
Lonza
@LonzaGroup
Congrats to James Taylor, Senior Scientist R&D #lonza, for receiving the award for best speaker at @ESACTUK conference 2019. ESACT-UK promotes the communication of knowledge between scientists & engineers in the area of cell culture biotechnology. Good job James!
-
Lonza
@LonzaGroup
Our Cell & Gene Technologies Head, Alberto Santagostino, will join the panel discussion next week at Fierce Biotech during the J.P Morgan Healthcare Conference 2020 in San Francisco, CA. We hope to meet you there! #nexttogether #celltherapy #genetherapy pages.questexnetwork.com/FierceBiotech-2020-JPMorgan.html…
-
Lonza
@LonzaGroup
Drug Developers Take Fresh Aim at 'Guided-Missile' Cancer Drugs www.nytimes.com/reuters/2020/01/06/world/europe/06reuters…
-
Lonza reposted
The Medicine Maker
@medicine_maker
Gordon Bates from @LonzaPB says that biologics are not the only big players in #pharma. Small molecules continue to play a significant role in the development of innovative treatments
themedicinemaker.com/manufacture/why-small-molecules-are-… -
Lonza
@LonzaGroup
Happy Holidays from our @LonzaGroup family to yours!
-
Lonza reposted
CHEManager
@chemanager
Die @LonzaGroup erweitert derzeit mit #ibex Solutions seinen #biopark im schweizerischen Visp. Das #engineering dafür liefert die österreichische #zeta GmbH aus #lieboch bei #graz. www.linkedin.com/feed/update/urn:li:activity:661267225807…
-
Lonza reposted
Cryoport
@cryoport
Among the many accomplishments we’re celebrating this year, we’re thrilled to have established partnerships with @LonzaBP, @LonzaGroup, @Vineti, @EVERSANA, and more: cyrx.co/2019milestones
-
Lonza
@LonzaGroup
Gordon Bates, #lonza CHEM President, explains why small molecules are still a big deal for pharmaceutical innovation in @medicine_maker
The Medicine Maker
@medicine_maker
Though large molecules and advanced therapies currently dominate headlines, small molecules remain of great significance for the industry – and patients, says Gordon Bates @LonzaPB
Click below to read more:
themedicinemaker.com/manufacture/why-small-molecules-are-… -
Lonza reposted
Scientific Update
@SciUp
Brendon Doyle @LonzaGroup who was one of our winners of our Young Chemist Award at our 6th Winter Process Chemistry Conference #wpc19
-
Lonza
@LonzaGroup
Gordon Bates, President #lonza Chem Division, shares his views on small molecule trends – and why they are still game-changers for developing innovative therapies. themedicinemaker.com/manufacture/why-small-molecules-are-…
-
Lonza reposted
RegMedNet
@RegMedNet
Check out our exclusive #genetherapy infographic, in partnership with @LonzaGroup, where we share the results of our latest survey, only on @RegMedNet now.
www.regmednet.com/infographics/gene-therapy-in-practice-c… -
Lonza
@LonzaGroup
Surrounded by the majestic Swiss Alps, our #lonza site in #visp (CH) is the heart of our business – the place from which we grew from a local business to a multinational company. We're constantly growing & looking to recruit about 700 people in the coming years! #biotechvalais
Heidi.news
@heidi_news
Matthieu Stettler, responsable des services de développement Ibex chez @LonzaGroup: «On a l'ambition de recruter 700 personnes dans les années qui viennent» #biotechvalais
-
Lonza
@LonzaGroup
Congrats to our @LonzaPB team for winning the #cphiaward for Pharma Service Company of the Year!
-
Lonza reposted
Genetic Engineering & Biotechnology News
@GENbio
. @LonzaGroup Talks Biopharma’s Digital Future -- www.genengnews.com/news/lonza-talks-biopharmas-digital-fu…
-
Lonza
@LonzaGroup
Watch this video to learn how Lonza is helping to reshape the future of #cancercare!We're contributing to an emerging class of medicines, called #adcs, which deliver stronger therapeutic effects & contribute to a better quality of life for cancer patients. www.youtube.com/watch?v=XxIjbbblvpU
-
Lonza reposted
Synthace
@synthace
Marc Funk, CEO of @LonzaGroup, highlights the importance of #automation and 3D Bioreactors for innovating to overcome the challenges in #cgt development in this article in @BioPharmaReport. www.biopharma-reporter.com/Article/2019/11/04/Lonza-CEO-o…
-
Lonza reposted
Cryoport
@cryoport
NEW: Lonza Selects Cryoport to Strengthen Its 'Vein-to-Vein' Delivery Network in Cell & Gene Therapy @LonzaPB @LonzaGroup
cyrx.co/36AiVcj -
Lonza reposted
Outsourcing-Pharma
@OutsourcPharma
The Top 5 CDMOs collectively account for approx. 15% of the market, which is valued at $92.3bn, per @ResultsIG >>
1️⃣ @LonzaGroup
2️⃣ @CatalentPharma
3️⃣ @Patheon
4️⃣ @RecipharmAB
5️⃣ Siegfried
#cphiworldwide panelists expect significant consolidation: www.outsourcing-pharma.com/Article/2018/10/22/Top-5-CDMOs… -
Lonza reposted
Xconomy
@Xconomy
Tomorrow! Our free symposium highlights new approaches to progress therapeutic proteins from discovery to the clinic. Hear from @BiocominSF/@biocom/@BiocomSFExecDir, @LonzaPB/@LonzaGroup, @FortySevenInc & more. Register:
xconomy.com/biopharma-disc… #xconpharmasf @BioProcessIntl -
Lonza reposted
ADC Review
@ADCReview
Join Lonza Pharma & Biotech in Frankfurt, Germany for CPhI Worldwide 2019 from 5th to 7th November at booth no. 121C10 ICSE Hall 12.1 - adc.expert/LonzaCPHI2019
#adc #hiapi #cancertreatment
#drugdevelopment @CPhIWW @LonzaGroup @LonzaBioRes @LonzaPB #biologics #pharma #cdmo -
Lonza reposted
Xconomy
@Xconomy
Next week! Our free symposium highlights new approaches to successfully progress therapeutic proteins from discovery to the clinic. Hear from @UCSanDiego, @LonzaPB/@LonzaGroup, Avidity Biosciences & more. Register:
xconomy.com/biopharma-discovery-to-clinic-san-diego/ #xconpharmasd @BioProcessIntl -
Lonza reposted
Xconomy
@Xconomy
Next week! Our free symposium highlights new approaches to progress therapeutic proteins from discovery to the clinic. Hear from @BiocominSF/@biocom/@BiocomSFExecDir, @LonzaPB/@LonzaGroup, @FortySevenInc & more. Register:
xconomy.com/biopharma-discovery-to-clinic-san-francisco/ #xconpharmasf @BioProcessIntl -
Lonza reposted
BIOGA
@BiogaCluster
Visítanos en el stand B4 de Feria Internacional de Empleo Universitario #findeu para conocer todo el potencial del ecosistema #biotech gallego y las empresas que conforman Bioga Galicia como @GalChimia y @LonzaGroup que también nos acompañan en este evento.
¡Os esperamos! -
Lonza reposted
FoodIngredients1st
@FoodIng1st
Science-led #power boost: Lonza’s #vegan formulation broadens company scope for #sportsnutrition ingredients www.nutritioninsight.com/news/science-led-power-boost-lon… @LonzaGroup #muscleguard #lcarnitine #creatine
-
Lonza reposted
ManufacturingChemist
@manchempharma
The agreement with @Mesoblast provides for @LonzaGroup to expand its Singapore cGMP facilities if required to meet long-term growth and capacity needs for the product candidate www.manufacturingchemist.com/news/article_page/Mesoblast_…
-
Lonza
@LonzaGroup
-
Lonza
@LonzaGroup
Mesoblast & Lonza entered into an agreement for the commercial manufacture of Mesoblast’s lead allogeneic (off-the-shelf) cell therapy product candidate. Manufacturing will take place in Lonza’s Singapore cGMP facility. More info: www.lonza.com/about-lonza/media-center/news/Tensid/2019-1… #celltherapy #allogeneic
-
Lonza
@LonzaGroup
@LonzaGroup extends its partnership with @Genmab to cover development and clinical manufacturing of drug substance and drug product for certain programs in Genmab’s pre-clinical and clinical pipeline. #lonzaibexsolutions www.lonza.com/about-lonza/media-center/news/Tensid/2019-1…
-
Lonza reposted
CHEManager International
@CHEManager_EU
Good morning, #switzerland. Since no way is too difficult for our #readers and #followers, we have sent our best men, Jan Kaeppler and Michael Reubold to #visp to take a look at the state-of-the-art location of the @LonzaGroup. Stay tuned. @LonzaPB
-
Lonza reposted
CHEManager International
@CHEManager_EU
Today we are on the road at the Visp site of @LonzaPB. We will have a look at the investments in the expansion project and get a first impression of the plant.
-
Lonza
@LonzaGroup
Join Lonza in Frankfurt (DE) for #cphiworldwide! Meet our teams from @LonzaPB (booth 121C10) and @CapsugelNews (booth 102A70 ). For more info on Pharma & Biotech visit www.lonza.com or go.capsugel.com/meetcapsugelatcphi for Capsugel related news. #nexttogether #capsugelcphi
-
Lonza
@LonzaGroup
Lonza and Prevail Therapeutics announced today their strategic collaboration to develop and manufacture Prevail’s novel AAV9 gene therapy programs for patients with neurodegenerative diseases: www.lonza.com/about-lonza/media-center/news/Tensid/2019-1…
-
Lonza reposted
Biopharma Dealmakers
@bpdealmakers
In the first of our new BioPharma Thought Leaders series, Marc Funk, CEO of
@LonzaGroup talks to us about the new business models and technology the company is developing to help small biotech companies remain independent: go.nature.com/2kEEEga #biotech #thoughtleaders -
Lonza
@LonzaGroup
Our Singapore cell and gene therapy manufacturing facility hosted Senior Minister and Coordinating Minister for National Security Teo Chee Hean and delegates from EDB, A*Star, NRF and Temasek on 9 Sep.
Photos credit: Ministry of Communications and Information -
Lonza
@LonzaGroup
Want to learn more about Lonza's science-backed ingredients and cutting-edge dosage forms? Come visit our experts this week at Food Ingredients Asia in Bangkok, stand C20.
-
Lonza
@LonzaGroup
Introducing the NUGEN®NR Disinfectant Wipes - No rinse required so the possibilities are endless! hashtag#Lonza hashtag#KeepingOurWorldHealthy
Watch the new video www.youtube.com/watch?v=78bimokWNgo -
Lonza
@LonzaGroup
Our commercial mammalian facility in Singapore will be supporting @CelltrionDream for supply of #remsima. This paves the way for broader patient access to affordable, life-changing therapies for people suffering from many autoimmune diseases. www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Bringing life-saving medicines to patients worldwide is a priority for #lonza. We’re partnering with @OmerosCorp to support future commercial production of narsoplimab, a monoclonal antibody designed to treat certain complications of stem cell transplants.www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Following the announcement of a successful H1 with a 6.4% rise in sales, our CEO Marc Funk talks to @CNNMoneyCH about the challenges and opportunities in our business. www.cnnmoney.ch/shows/living-markets/videos/how-lonza-wil…
-
Lonza
@LonzaGroup
LSI carve-out progressing on time and on budget www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzahyr
-
Lonza
@LonzaGroup
Cell and Gene Technologies showing strong inflow of new clinical and commercial contracts www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzahyr
-
Lonza
@LonzaGroup
Lonza supports biopharmaceutical partners globally. In H1 we announced Alector, AstraZeneca and Gamida Cell www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzahyr
-
Lonza
@LonzaGroup
Key message from CEO Marc Funk on #2019lonzahyr www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Double-digit sales growth delivered by Pharma Biotech & Nutrition (LPBN) segment www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzahyr
-
Lonza
@LonzaGroup
Lonza on track to deliver Full-Year 2019 results, driven by Pharma Biotech Business www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzahyr
-
Lonza
@LonzaGroup
Lonza expands bioconjugation facility and announces approval of third commercial ADC www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Lonza to acquire sterile fill and finish facility from @Novartis extends Lonza Pharma & Biotech’s current parental drug product services to enable commercial launch. Read the news release here: www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Gordon Bates, President of the Chemical Division at Lonza Pharma & Biotech, talks about how CDMO can support customers in China. Are you interested to know more? Watch the interview! www.cphi.com/china/visit/news-and-updates/how-cdmos-can-s…
-
Lonza
@LonzaGroup
.@GamidaCellTx and Lonza announced today the signing of a commercial manufacturing agreement, including dedicated suites in Lonza’s Geleen (Netherlands) site for Phase 3 investigational advanced cell therapy omidubicel. Read the full press release here. www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
To address growing demand for #hpapi drugs, #lonza will add two new HPAPI production lines to our Visp, CH site. Lonza has also entered a long-term manufacturing agreement with @AstraZeneca which the new facility will support. Read more here: www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Join the Lonza team to discover how the new Lonza Engine™ equipment portfolio is designed to support bioavailability enhancement, encapsulation and early-phase clinical development technologies. Watch the webinar on 25 June at 9am EDT www.capsugel.com/webinars/webinar-accelerate-your-drug-de…
-
Lonza
@LonzaGroup
Lonza launches Lonza Engine™, a comprehensive equipment offering for the drug development and manufacturing process. Read the press release to learn more. www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Message from Sven Abend on today's news:
-
Lonza
@LonzaGroup
Message from Marc Funk on the carve-out of Lonza's Specialty Ingredients:
-
Lonza
@LonzaGroup
The carve-out will enable LSI to grow and strengthen its leading role in microbial control. www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Specialty Ingredients (LSI) will operate independently, but remain a fully owned segment of Lonza Group www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Carve-out of Lonza Specialty Ingredients will help segment to become a global leader in microbial control: www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
The Capsugel® Zephyr™ dry-powder inhalation capsule portfolio offers ideal puncturing and cutting performance. Watch the webinar on Thursday, May 23, at 11 AM EST to learn more about our DPI drug delivery platform. #dpi www.capsugel.com/webinars/webinar-discover-the-capsugel-d…
-
Lonza
@LonzaGroup
Today Lonza Visp (CH) welcomed the Healthcare Club of the @HSGStGallen. The students had the opportunity to learn about Lonza’s business through presentations and a tour through the facility. It was great having them here!
-
Lonza reposted
Vitafoods
@Vitafoods_
Impossible to miss, the @LonzaGroup stand welcomed all our #vfe19 visitors with their impressive display! We want to thank our Official Capsule Sponsor for their support and for bringing colour to our show! Learn more about their #cleanlabel food colored capsules @CapsugelNews
-
Lonza
@LonzaGroup
Lonza’s Professional Hygiene Team has launched two NEW Hydrogen Peroxide products for the North American market. Watch the new video youtu.be/v09U26cAawk and for more product details, click mailchimp.com/about/mcsv-static
-
Lonza
@LonzaGroup
Today is world #handhygiene day! Healthcare-associated infections are a major threat in all healthcare settings. #handhygiene is one of the best things to protect patients. Visit the @WHO webpage for more info: www.who.int/infection-prevention/campaigns/clean-hands/5m…
-
Lonza
@LonzaGroup
‘CLEAN CARE FOR ALL - IT'S IN YOUR HANDS’ is a special lecture, taking place today as part of the @WHO 5 May #handhygiene campaign. Register for the teleclass at: webbertraining.com/schedulep1.php?command=viewClass&ID=1440 #healthforall #infectionprevention
-
Lonza
@LonzaGroup
#handhygiene is essential for #infectionprevention. Check out: “It’s in Your Hands” - the official song featuring @DidierPittet released to celebrate the forthcoming World #handhygiene Day on 5 May. www.youtube.com/watch?v=ABzRdMw26E0 #healthforall @GLOBAL_POPS @WHO
-
Lonza
@LonzaGroup
Our people are the cornerstone of our business, so we want all our employees to grow and develop professionally at a sustainable pace. More than five years ago, Lonza took a step up to operate even more safely and sustainably by announcing our Vision Zero. www.lonza.com/annualreport/
-
Lonza reposted
RegMedNet
@RegMedNet
Just two days left to register for our panel discussion - join our experts as they discuss development of a #regenerativemedicine business strategy, global access, and the challenges of automation and integration @Lonza @MaxCyte_info event.on24.com/eventRegistration/unavailable?&eventid=195…
-
Lonza
@LonzaGroup
Today we are celebrating World Day of Safety and Health at work.
-
Lonza reposted
Lonza LAL
@Lonza_LAL
Let’s stop for a moment and appreciate the amazing wildlife from the sea. Spawning #horseshoecrabs: several female horseshoe crabs are surrounded by male suitors, ensuring the fertilization of eggs. #earthday
-
Lonza
@LonzaGroup
The nutrition business has introduced new nutritional offerings to deliver constant innovation for fast-moving consumer goods markets, e.g. cooperation with DuPont Nutrition & Health to supply a human milk oligosaccharide for infant formulas www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzaq1
-
Lonza
@LonzaGroup
As part of its strategy to invest in innovative technologies and new ventures, Lonza announced a unique partnership with Chr. Hansen A/S, a leading global bioscience company, to pioneer the microbiome space. www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzaq1
-
Lonza
@LonzaGroup
CEO Marc Funk giving his speech to AGM 2019 now
-
Lonza
@LonzaGroup
Meeting with a speech and welcomes our shareholders. "We are grateful to you, our shareholders, for the faith you have demonstrated in Lonza with your ownership."
-
Lonza
@LonzaGroup
In Q1 Lonza started to bring its Cocoon™ autologous cell therapy in-a-box manufacturing device to the clinic in a pilot project with Sheba Medical Center, the largest hospital in Israel. www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzaq1
-
Lonza
@LonzaGroup
First customers for Lonza's innovative full-service, all-at-one-site clinical offering Ibex™ Design & Develop in Visp (CH) are committed www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzaq1
-
Lonza
@LonzaGroup
Everything’s ready for the AGM 2019! Doors are open for our shareholders and guests.
-
Lonza
@LonzaGroup
The Outlook 2019 as communicated with the Full-Year 2018 results in January 2019 is confirmed: Mid-to-high-single digit sales growth & sustained high CORE EBITDA margin level www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzaq1
-
Lonza
@LonzaGroup
Equilibrium is achieved, as challenges in LSI are balanced by outperformance in LPBN. Outlook 2019 is confirmed. www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Lonza had a solid start to the year 2019 with continued positive momentum in its core healthcare businesses www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #2019lonzaq1
-
Lonza
@LonzaGroup
Key message from CEO Marc Funk on #2019lonzaq1: “My vision is to further accelerate growth in our core healthcare businesses and constantly innovate with new offerings for our customers and their patients and consumers."
-
Lonza
@LonzaGroup
#2019lonzaq1 Pharma Biotech & Nutrition businesses continue to drive Lonza performance in Q1 2019 www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
At Lonza we continue to improve our environmental footprint by continually reducing energy, water & material demand per unit. With a long–term view to 2030, we aim to achieve a 50% reduction of our CO2 footprint. #parisagreement www.lonza.com/annualreport/
-
Lonza
@LonzaGroup
Manufacturing #cancer treatments at the point of care. i24NEWS reports on our partnership with Sheba - Tel Ha SHomer Hospital to bring #autologous CAR-T therapies closer to patients using Cocoon. #nexttogether #celltherapy @SHEBA_ #genetherapy www.youtube.com/watch?v=bxGEo8Y0tCc
-
Lonza
@LonzaGroup
Are you looking for an internship, apprenticeship, or a full-time position? Lonza will be at Chemtogether 2019 at ETH Zürich (CH). Mark your calendars: Stop by on Tuesday, November 5th to learn more about the company and employment
opportunities! www.chemtogether.ethz.ch -
Lonza reposted
Capsugel®
@CapsugelNews
Did you miss the Capsugel® Vcaps® Plus Webinar? Watch it on-demand. event.on24.com/eventRegistration/EventLobbyServlet?target…
-
Lonza reposted
in-cosmetics
@incosmetics
The #formulationchallenge is about to begin! Come on over to Formulation Lab 2 to watch our competitiors battle it out for the crown! #incosglobal @LonzaGroup #cosmetics #manufacturers
-
Lonza
@LonzaGroup
LIVE News Conference at Lonza HQ on our recent Joint Ventiure with @Chr_Hansen
-
Lonza
@LonzaGroup
Lonza and @Chr_Hansen have signed an agreement to establish a 50/50 joint venture to become the pioneer in the live biotherapeutic products industry and to position themselves as the leading CDMO for pharma and biotech customers. Read here: www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Join us at In-Cosmetics Global at Booth L88 to see the launch of our amazing new products, including Syneth™ #lonza #makemorepossible www.youtube.com/watch?v=qA5g356j9iE
-
Lonza
@LonzaGroup
Lonza announced yesterday the next stage in the evolution of its market-leading GS Xceed® expression platform with the launch of GS piggyBac™, a highly efficient gene integration technology. Learn more here: www.lonza.com
-
Lonza
@LonzaGroup
Long & confusing ingredient labels weighing you down? Come visit booth L88 at In-Cosmetics on April 2-4 to find out about Lonza’s simple solutions to a more natural preservation approach. www.lonza.com/products-services/consumer-health/preservat… or contact us at preservation@lonza.com #lonza #makemorepossible
-
Lonza
@LonzaGroup
One of Lonza’s long-term goals is to improve our sustainability performance and reduce our environmental footprint. To achieve these aspirations, Lonza has set specific environmental targets. Are you interested in learning more? Click here! www.lonza.com/annualreport/
-
Lonza
@LonzaGroup
Are you looking to start your career in a global life-sciences company? Come to meet our team at #jobvector Career Day in Frankfurt, Germany, on 27 March, and learn about our job opportunities at Lonza in Visp (CH)!
-
Lonza
@LonzaGroup
.@SHEBA_ and #lonza look to advance the next personalized cell-therapy revolution. In collaboration with Sheba Medical Center, Lonza will use its #cocoon platform to help develop scalable point-of-care cell-therapy manufacturing for #cancer patients www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza reposted
Lonza LAL
@Lonza_LAL
As an attendee at our Global #endotoxin Testing Summit, you will get the opportunity to travel to a horseshoe crab sanctuary beach, observe the crabs' annual spawning ritual and gain hands-on insight into this ancient mariner. #2019endosummit www.lonza.com/endosummit
-
Lonza
@LonzaGroup
It has been Lonza's commitment and strategy throughout the last decade to reduce our energy, water usage and waste intensity, as well as our rate of accidents and incidents. Check out the infographic. Click here to read our Sustainability Report www.lonza.com/annualreport/
-
Lonza
@LonzaGroup
The 18th Congress of the Japanese Society for Regenerative Medicine takes place on 21-23 March in Kobe, Japan. We'll be there, and you? www.lonza.com/about-lonza/knowledge-center/events/pharmab…
-
Lonza
@LonzaGroup
Meet our experts at DMDG Toxicology Symposium on 21 March in Nether Alderley, UK. www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Looking forward to #cphijapan on 18-20 March in Tokyo!
-
Lonza
@LonzaGroup
Lonza will be attending the PDA Parenteral Packaging on 19-20 March in Venice (IT)! Come and meet us!
-
Lonza
@LonzaGroup
Today we're celebrating #iwd2019 together with @AdvanceWomenCH, an association and network that takes specific measures to increase the share of women in leading positions in Switzerland. #weadvance #bettertogether
-
Lonza
@LonzaGroup
Together with the 2018 Annual Report, we published our first Sustainability Report. Check it out now! www.lonza.com/annualreport/
-
Lonza
@LonzaGroup
Today we published our 2018 Annual Report. Click here to read about Lonza’s year! annualreport.lonza.com/2018/
-
Lonza
@LonzaGroup
Our experts will be waiting for you at booth # 206 on March 11-14 at #bpiwest in Santa Clara, CA (USA).
-
Lonza
@LonzaGroup
Attend #sot2019 on 10-14 March in Baltimore, MD (USA) and meet our experts at booth # 3322! See you there!
-
Lonza
@LonzaGroup
Today is the first day for our new CEO Marc Funk, who moves from the role of COO of the Pharma & Biotech segment to lead Lonza Group.
-
Lonza
@LonzaGroup
Lonza completes divestment of Water Care business www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
It was great to hear the insightful #infectionprevention presentations and meet with visitors at #ipc2019london! Were you unable to attend & want to learn more about Lonza’s informatics solutions for environmental monitoring? Email us! infectionprevention@lonza.com @KnowlexUK
-
Lonza
@LonzaGroup
Meet Stefan Stoffel, new Executive Committee member as COO of Lonza Pharma Biotech & Nutrition (LPBN). Stefan joined Lonza in 1991 working in a number of roles of increasing responsibility within the organization. All the best in your new role, Stefan! www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Come by to meet our team and learn more about our #informaticssolutions!
-
Lonza
@LonzaGroup
Meet our experts at NVGCT Spring Symposium on 6-8 March in Lunteren, the Netherlands! www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Lonza strengthens Pharma, Biotech and Nutrition offerings with aligned structure and new Executive Committee appointment. Read the full press release under: www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
We're excited to be exhibiting at #ipc2019london! Visit stand 6 to learn about Lonza’s Informatics solutions for environmental monitoring for #infectionprevention. @KnowlexUK
Knowlex
@KnowlexUK
We look forward to seeing you at #ipc2019london @LonzaGroup
-
Lonza reposted
Clinical Services Journal
@CSJMagazine
Infection Prevention with Lonza www.clinicalservicesjournal.com/story/27466/infection-pre…
-
Lonza
@LonzaGroup
At the Annual General Meeting, the Board of Directors will propose a stable dividend for shareholders of CHF 2.75 per share for 2018 www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzafullyear18
-
Lonza
@LonzaGroup
Lonza launched further growth initiatives to expand its global and technological footprint, especially in biologics, including the expansion of Ibex™ Solutions in Visp (CH) www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzafullyear18
-
Lonza
@LonzaGroup
Having completed the first full year as a combined company, Lonza continued to benefit from the performance and synergistic potential of the successfully integrated Capsugel businesses www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzafullyear18
-
Lonza
@LonzaGroup
The Consumer Health division performed strongly with continued momentum particularly in Consumer Health and Nutrition and benefited from synergies across nutritional ingredients, formulation capabilities and dosage form offerings. www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzafullyear18
-
Lonza
@LonzaGroup
Lonza's Specialty Ingredients segment contributed to #lonzafullyear18 with 3.4% organic sales growth and a 22.1% CORE EBITDA margin, despite headwinds due to raw-material price increases, supply-chain challenges and negative cyclical impacts www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
-
Lonza
@LonzaGroup
Outperformance in Pharma & Biotech – with 14% sales growth and margins up 260 bps – was combined with positive momentum in the Consumer Health division www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzafullyear18
-
Lonza
@LonzaGroup
Lonza delivered our Full-Year 2018 results with sales of CHF 5.5 billion at a record level of profitability with 27.3% CORE EBITDA margin for Lonza’s continuing operations www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzafullyear18
-
Lonza
@LonzaGroup
Key message from Marc Funk, Incoming CEO of Lonza. See full news release at: www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzanewceo
-
Lonza
@LonzaGroup
Lonza Announces Succession of CEO www.lonza.com/about-lonza/media-center/news/Tensid/2019-0…
#lonzanewceo -
Lonza
@LonzaGroup
Key message from Richard Ridinger, CEO Lonza, on our #lonzafullyear18 results. See full news release at: www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzafullyear18
-
Lonza
@LonzaGroup
Lonza achieved another excellent Full-Year Result in 2018 with 9% organic sales growth and strong profitability driven by healthcare businesses: www.lonza.com/about-lonza/media-center/news/Tensid/2019-0… #lonzafullyear18
-
Lonza
@LonzaGroup
Meet us at #slas2019 on 4-6 February in Washington, DC. You can find us at booth # 749. www.lonza.com/about-lonza/knowledge-center/events/pharmab…
-
Lonza
@LonzaGroup
LIVE from @Phacilitate Leaders Miami: Alberto Santagostino opening the plenary session to kick-off the conference. We hope to meet you later at our booth #407 to discuss your cell and gene therapy manufacturing solution. #nexttogether #celltherapy #genetherapy
-
Lonza
@LonzaGroup
Lonza will participate in the European Workshop on Protein Aggregation and Immunogenicity on 28-29 January in Salzburg-Wals (Austria). www.lonza.com/about-lonza/knowledge-center/events/custom-…
-
Lonza reposted
Prof Didier Pittet
@DidierPittet
Mark your 📅. Webber teleclass on Jan 17 to launch @WHO GLOBAL SURVEY promoting the monitoring of @WHO core components for #infectionprevention and #handhygiene Self Assessement register here: webbertraining.com/schedulep1.php?command=viewClass&ID=1468 …@SHEA_Epi @APIC @IPS_Infection
-
Lonza
@LonzaGroup
Lonza is attending this year's @BioSeedEvent on 16 January in London, UK. www.lonza.com/about-lonza/knowledge-center/events/custom-…
-
Lonza
@LonzaGroup
Looking for more content on drug solubility and enhancement of solubility or dissolution rate? We promote our bioavailability enhancement content on our dedicated Lonza Pharma & Biotech channel. Follow @LonzaPB today! #nexttogether
-
Lonza
@LonzaGroup
The Lonza Family wishes you all a Happy New Year 2019! May all your wishes come true.
-
Lonza
@LonzaGroup
Happy Holidays from Our Lonza Family to Yours!
-
Lonza
@LonzaGroup
We caught up with Alberto Santagostino, our recently appointed Business Unit Head of Cell and Gene Technologies (CGT) in between the ESGCT conference and a visit to Lonza’s Netherland site for cell and gene therapy manufacturing. Read the short interview: www.lonza.com
-
Lonza
@LonzaGroup
Follow our @LonzaPB channel to learn more about our services that enable pharma and biotech companies to bring medicines to patients in need. #nexttogether #pharma #biotech
-
Lonza reposted
Lonza BioResearch Solutions
@LonzaBioRes
The 2018 ASCB/EMBO Annual Conference has begun in beautiful San Diego, California! If you are planning to attend, be sure to visit Lonza staff (booth #530) now through Dec 12, to discuss your primary cell research. See you there! #ascbembo18 #cellbiology www.ascb.org
-
Lonza
@LonzaGroup
Lonza is pleased to be sponsoring a Webber Training teleclass in December 2018 on the topic of infection prevention and control. To view the teleclass schedule please visit: webbertraining.com/schedulep1.php
-
Lonza
@LonzaGroup
Developers of drug-device combination products can face challenges with formulation, stability, packaging and application. #lonzadrugproduct expert R. Mathaes discusses these challenges and ways to minimize their impact on your product. Learn more: curtiswyss.com/events/drugdevice-healthcare
-
Lonza
@LonzaGroup
Come by at booth #528 at the ASCB/EMBO 2018 in San Diego, CA. We'll be happy to see you on 8-12 December! events.jspargo.com/ascb18/Public/Enter.aspx
-
Lonza
@LonzaGroup
Lonza is attending the Mercia Stem Cell Alliance Meeting on 7 December at the University of Birmingham, UK. www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Meet us at #chinacoat2018 on 4-6 December in Guangzhou, China. @CHINACOAT www.lonza.com/about-lonza/knowledge-center/events/industr…
-
Lonza
@LonzaGroup
Looking forward to attend the @ACTCconference on 4-5 December at University of Cambridge (UK)! www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Meet us at the Cell Therapy Manufacturing and Gene Therapy Congress on 4-6 December in Amsterdam, the Netherlands. www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
See you next Friday, 30 November, at the 8th Annual UK & Ireland Early Career BBB Symposium, University of Oxford (UK). www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Wondering why you haven’t seen a post on an upcoming webinar or talk in cell therapy manufacturing recently? That’s because Lonza Pharma & Biotech has its own channel now! Follow @LonzaPB to stay up to date with all Lonza Pharma & Biotech related activities. #nexttogether
-
Lonza
@LonzaGroup
Lonza is participating in the 26th Pharmig Annual Meeting on 28-30 November in Nottingham, UK.
-
Lonza
@LonzaGroup
Meet us at #debs on 21-23 November in Amsterdam, The Netherlands.
-
Lonza
@LonzaGroup
Lonza will be at the A3P International Congress in Biarritz, France, on 13-15 November.
-
Lonza
@LonzaGroup
Fatma Senkesen, Head of Market Insights at Lonza, will be presenting at the Cell & Gene Therapy Manufacturing Forum. Don't miss it out! London, 13-15 November.
-
Lonza
@LonzaGroup
Meet us at the Oxford Stem Cell Institute Symposium on 12-13 November, University of Oxford, UK.
-
Lonza
@LonzaGroup
“We are putting the Water Care business in the hands of an experienced owner who will develop Water Care as a stand-alone business while focusing on innovation and further growth," said Richard Ridinger, CEO of Lonza. www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
Lonza further strengthens focus on its healthcare continuum strategy by signing an agreement to divest Water Care business to Platinum Equity www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza reposted
Lonza BioResearch Solutions
@LonzaBioRes
Join our fun Treasure Hunt game! Explore the new features of Lonza's recently launched Bioscience website, solve the clues and enter the prize draw for a chance to win a 50 USD / EUR / GBP Amazon voucher. Join the Treasure Hunt :bioscience.lonza.com/lonza_bs/CH/en/home #bioscience
-
Lonza
@LonzaGroup
#jaact takes place on 5-8 November in Tsukuba, Japan. Lonza will be there, and you?
-
Lonza
@LonzaGroup
Come by at booth #3628 on 3-7 November at the Society for Neuroscience in San Diego, CA! Our experts will be there! www.sfn.org/meetings
-
Lonza
@LonzaGroup
“This acquisition is a clear message to the market that we are committed to making commercially viable and scalable personalized therapies a reality,” said Marc Funk, COO of Lonza Pharma & Biotech www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
The acquisition of Octane Biotech further strengthens Lonza’s commitment to drive the next generation of manufacturing patient-specific and personalized therapies www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
NEWS: Lonza acquires a controlling stake in Octane Biotech to further develop the Cocoon™ autologous technology www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
Q3 confirmed strategy update from Capital Markets Day in September for continued growth toward achieving Lonza’s Mid-Term Guidance 2022 and beyond #2018lonzaq3 www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
Although challenging environment for cyclical businesses in mature parts of portfolio continued to affect Consumer & Resources Protection, specialty composites portfolio sustained robust performance #2018lonzaq3 www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
Q3 announcement of Ibex™ Solutions expansion with new, innovative offerings from preclinical to commercial including fill & finish services was well received #2018lonzaq3 www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
Outlook for the full year, which was already upgraded with H1 2018 results, is confirmed #2018lonzaq3 www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
Businesses in Pharma & Biotech and in Consumer Health – including capsule and combined ingredient and dosage form offerings – as continued growth drivers #2018lonzaq3 www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
Key message from CEO Richard Ridinger on #2018lonzaq3:
"We are focusing our investments and initiatives on our core markets along the healthcare continuum." www.lonza.com/about-lonza/media-center/news/Tensid/2018-1… -
Lonza
@LonzaGroup
Lonza Continues Strong Momentum in Business Along the Healthcare Continuum in Q3 2018 and Confirms Positive Outlook for the Full Year www.lonza.com/about-lonza/media-center/news/Tensid/2018-1… #2018lonzaq3
-
Lonza
@LonzaGroup
Meet us at the #labinnovations2018 on 31 October and 1 November in Birmingham, UK!
-
Lonza
@LonzaGroup
Clean hands stop germs! Check out these great resources from @APIC during International Infection Prevention Week, 14-20 October and beyond! #iipw apic.org/cleanhandsstopgerms
-
Lonza
@LonzaGroup
International Infection Prevention Week (#iipw), 14-20 October, celebrates the importance of infection prevention and patient safety. Check APIC’s resources and spread the word that everyone plays a role in #infectionprevention. infectionpreventionandyou.org @APIC
-
Lonza
@LonzaGroup
#incosmetics goes to Bangkok, Thailand. Save the date: Oct 30 – Nov 1. Are you coming too? asia.in-cosmetics.com
-
Lonza
@LonzaGroup
Lonza is participating in the 10th Annual Cancer Science Unit on 19 October at the University of Southampton, UK. www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Join us at booth # 7 for the PDA Endotoxins Workshop on 17-18 October in Bethesda, MD, USA. www.lonza.com/about-lonza/knowledge-center/events/pharmab…
-
Lonza
@LonzaGroup
Last week, Lonza participated in the #recruitmilitary job fair, which helps connect employers to veterans. Missed the fair? Check our open positions here: lonza.wd3.myworkdayjobs.com/Lonza_Careers
-
Lonza
@LonzaGroup
Come and get a first glimpse of the next generation solution for endotoxin detection at the PDA Global Conference on Pharmaceutical Microbiology on 15-17 October in Bethesda, MD, USA. You can find us at booth #308! www.lonza.com/about-lonza/knowledge-center/events/pharmab…
-
Lonza
@LonzaGroup
Come and join the Lonza Hygiene & Personal Care teams at this year's SEPAWA Congress in Berlin 10-12 Oct - Stand 118/119. ow.ly/d/7YzG We look forward to seeing you! #lonza #sepawa
-
Lonza
@LonzaGroup
Today at our Visp site, together with Clovis Oncology Inc., we celebrated a grand opening of a new, dedicated production train for Rubraca® (rucaparib), Clovis’ drug for several ovarian cancer indications. Read the press release here: www.lonza.com/about-lonza/media-center/news/Tensid/2018-1…
-
Lonza
@LonzaGroup
Today we are excited to be at HISICON 2018, the XV National Conference of Hospital Infection Society India. Visit the Lonza booth to learn about informatics solutions for environmental monitoring in #infectionprevention & control. More: www.lonza.com/infection-prevention
-
Lonza
@LonzaGroup
It was a pleasure to meet you at the #jobvector Career Day in Berlin last week. Thank you all for the great interest in Lonza! Visit our career portal: lonza.wd3.myworkdayjobs.com/Lonza_Careers
-
Lonza
@LonzaGroup
News: @exosomics_dx receives the 2018 Enabling Technology Leadership Award from @Frost_Sullivan in the #exosomebased #liquid #biopsymarket www.frost.com
-
Lonza
@LonzaGroup
Follow the new @LonzaPB channel to learn more about our services that enable pharma and biotech companies to bring medicines to patients in need. #nexttogether #pharma #biotech
-
Lonza
@LonzaGroup
Thanks to all our visitors at #aheexchange. It was great to see you there! Were you unable to attend and want to learn more about #lonza’s informatics solutions for environmental monitoring in #infectionprevention and control? More info: www.lonza.com/infection-prevention
-
Lonza
@LonzaGroup
As reported by the @HOUBizJournal, our new Pearland facility opened in April will host a career fair tomorrow. Pre-register at lonza.com/Houston. We hope to see you there! www.bizjournals.com/houston/news/2018/09/18/biotech-co-ho…
-
Lonza
@LonzaGroup
Lonza was pleased to take part in the exciting Hand Hygiene Self-Assessment Framework CrashCourse in Geneva. Thanks to Prof. @DidierPittet and colleagues for very informative sessions. @Global_POPS @WHO #handhygiene #infectionprevention
Prof Didier Pittet
@DidierPittet
Following a successful training on #infectionprevention #handhygiene @GLOBAL_POPS @WHO #geneva
-
Lonza
@LonzaGroup
The 17th Annual Contracting & Outsourcing Conference takes place on 27-28 September in New Brunswick, NJ, USA. Have you added it to your calendar? conference.contractpharma.com
-
Lonza
@LonzaGroup
Can you imagine having an Informatics Platform for Environmental Monitoring that schedules testing, captures all test results, tracks trends, produces reports and sends alerts? Visit the #lonza Booth (732) to find out more #aheexchange #infectionprevention @AHEtweets
-
Lonza
@LonzaGroup
Our Ibex™ Solutions offering is expanding. Read the press release here: www.ibex.lonza.com #ibexsolutions #nexttogether
-
Lonza
@LonzaGroup
See you in Warsaw on 26-27 September for the #hpci Poland! 10times.com/hpci-central-europe
-
Lonza
@LonzaGroup
The XXIV Annual Meeting German Society of Gene Therapy takes place on 26-28 September in Freiburg, Germany. Lonza will participate too! www.dg-gt.de
-
Lonza
@LonzaGroup
The PDA/FDA Joint Regulatory Conference is scheduled for 24-25 September in Washington, DC. Come by at booth #40 and meet our experts! www.pda.org/global-event-calendar/event-detail/2018-pda-f…
-
Lonza
@LonzaGroup
Learn more about our capsules and filling solutions at the JRS® Pharma Excipients and Coating systems #seminar on 18-19 September in Moscow, Russia.
-
Lonza
@LonzaGroup
Thank you all for meeting us at @processnet_org in Aachen (Germany). Check out more career opportunities at Lonza: lonza.wd3.myworkdayjobs.com/Lonza_Careers
-
Lonza
@LonzaGroup
Today, we launched our #earlyintermediates supply initiative to create greater value for #api supply. The initiative leverages our #visp Centre of Excellence to manufacture non-cGMP intermediates in ISO-Certified facilities www.lonza.com/about-lonza/media-center/news/Tensid/2018-0… #lonza #smallmolecules
-
Lonza
@LonzaGroup
Meet us at booth B8 at the Maghreb Pharma event on 17-19 September in Central Hall, Algiers, to learn more about our new innovative capsule, Colorista™, along with our biopharmaceutical innovations. www.capsugel.com/events
-
Lonza
@LonzaGroup
Visit Lonza Water Care at booth #1001 at the #awt2018 convention & expo. See you on 26-28 September in Orlando, FL.
-
Lonza
@LonzaGroup
How can an increased flexibility and high quality in Early Intermediates manufacturing help you achieve your goals for delivering a cost-efficient final product? Next week, 18 September, at 2.45pm EDT. For more information www.lonza.com
-
Lonza
@LonzaGroup
Lonza’s Dr. Michael Grass will present “Designing Amorphous Formulations and Manufacturing Processes for Challenging Compounds” this week at #ddfsummit. Don't miss it!
-
Lonza
@LonzaGroup
Let’s discuss navigating the next path to commercialization together. Dr. Thomas Fellner joins the opening panel at Cell & Gene therapy Phacilitate Europe next week. Hope to see you there! www.lonza.com
-
Lonza
@LonzaGroup
Excited for the #ddfsummit in San Francisco next week! Stop by booth 6 to discuss innovative solutions to the greatest challenges in pharma development #nexttogether
-
Lonza
@LonzaGroup
Check out this new article to learn more on all the different aspects of developing Dry Powder Inhalation capsule formulations, to achieve the desired performance for the capsule. Read more on: www.pharmtech.com/view/developing-capsules-dpis
-
Lonza
@LonzaGroup
Visit us at booth 171 at this year’s Water New Zealand Conference 2018 on 19-21 September in Hamilton, NZ. Lonza Water Care will present the benefits of dry chlorination systems. More info: www.lonza.com/about-lonza/knowledge-center/events/water/w…
-
Lonza
@LonzaGroup
Learn about new tools being developed outside the central dogma to support difficult-to-express proteins in a free webinar on 26 September. Register today: event.on24.com/eventRegistration/unavailable?&eventid=181…
-
Lonza
@LonzaGroup
Don’t miss our upcoming #webinar, 6 September at 11am, to learn how #capsugel #colorista can cut development time and enable greater flexibility in stability and compatibility testing. Register here: event.webcasts.com/starthere.jsp?ei=1204999&tp_key=3ff79c… and learn more about Colorista™ www.capsugel.com/biopharmaceutical-products/colorista-cap…
-
Lonza
@LonzaGroup
Meet us at the next annual meeting at Pharma ChemOutsourcing on 17-19 September in Long Branch, NJ, USA. For more information visit www.lonza.com
-
Lonza
@LonzaGroup
#incosmetics goes to Latin America. Save the date: Sept 19-20 in Sao Paolo, Brazil. Are you coming too? latinamerica.in-cosmetics.com
-
Lonza
@LonzaGroup
#iscteurope2018 on 12-14 September in Florence, Italy. We’re excited about the event. Are you? For info and registration: www.isct-eu2018.com
-
Lonza reposted
Capsugel®
@CapsugelNews
Don’t miss our upcoming #webinar, September 6 at 11am EST, to learn how #capsugel #colorista can cut development time and enable greater flexibility in stability and compatibility testing. Register here: event.webcasts.com/starthere.jsp?ei=1204999&tp_key=3ff79c… @LonzaGroup
-
Lonza
@LonzaGroup
Rajesh Beri to present on the BPOG Technology Roadmap initiative at this week’s #bpiconf in Boston. Learn more here: www.lonza.com
-
Lonza
@LonzaGroup
This year’s #phss conference takes place on 11 September in London, UK. The conference will address the key challenges in manufacturing and aseptic processing of Biological and Advanced Medicinal Therapeutic products. Join us! www.phss.co.uk/events/EventDetails.aspx?id=1038322
-
Lonza
@LonzaGroup
This week @CAR_TCell: Let’s discuss end-to-end patient-scale cell therapy manufacturing platforms together. Join us for a co-presentation with guest Octane Biotech. #nexttogether #car-T #autologous #manufacturing #cartcr #cartcrsummit
-
Lonza
@LonzaGroup
Join us at this year’s #basr Autumn Meeting 2018 and Early Career Symposium on 10-11 September in Sheffield, UK. bscr.org/event/bscr-autumn-meeting-2018-inflammation-and-…
-
Lonza
@LonzaGroup
Every great solution starts with curiosity and asking the right questions. What is your current challenge and what is the matching answer? Let’s talk about it at Chemicals America 2018, booth #515
-
Lonza
@LonzaGroup
#bas Autumn Meeting on 6-7 September in Cambridge, UK. Are you coming too? www.queens.cam.ac.uk/visiting-the-college/getting-to-queens/
-
Lonza
@LonzaGroup
Save the date! We’re excited to participate in the AHE's annual conference and exhibition, EXCHANGE 2018, 24-25 September 2018. Visit us at booth 732 to learn about Lonza’s informatics solutions for environmental monitoring for #infectionprevention. #aheexchange @AHEtweets
-
Lonza
@LonzaGroup
The #bsra takes place on 6-8 September in Oxford (UK), and we’ll be there. Join us! For info and registration: bsra.org.uk/bsra-2018-oriel-college-oxford-september-6-8-…
-
Lonza
@LonzaGroup
Meet us at the #eurotox2018 in Brussels, Belgium, on 2-5 September! We look forward to seeing you! www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Join us on 8 September from 10AM – 2PM for an interactive Career Fair at Lonza Portsmouth, New Hampshire (USA). Network with representatives from various functions and explore career opportunities. Register now to secure your spot: www.lonza.com/portsmouth See you there!
-
Lonza reposted
Capsugel®
@CapsugelNews
Don't miss our upcoming webinar, "Aging Well Before 30: The Millennial X Factor" on September 5! Register here: www.capsugel.com/webinars/webinar-aging-well-before-30-th…
-
Lonza
@LonzaGroup
Our next biologics conversation… let’s take it to Boston. Our experts will play an active role in the Biotech week, Bioprocessing International Conference and CAR-TCR Summit. Click here to find out more and arrange a meeting. #nexttogether pharma.lonza.com/events
-
Lonza
@LonzaGroup
New White Paper, “PyroGene™ rFC Assay” in @Lonza_LAL QC Insider™ Toolbox. Click here to read more about a sustainable #endotoxin detection method in your lab: www.lonza.com/qcinsider
Lonza LAL
@Lonza_LAL
Ready to consider a sustainable #endotoxin detection method in your lab? It’s easier than you think. Read our White Paper, “PyroGene™ rFC Assay” in our QC Insider™ Toolbox to learn more: www.lonza.com/qcinsider
-
Lonza
@LonzaGroup
New Interview from @AmPharmRev on Trends Driving Increased Outsourcing and Partnering in the Biopharma Industry. Read more: www.americanpharmaceuticalreview.com/Featured-Articles/35…
-
Lonza
@LonzaGroup
What's family life like in the heart of the Swiss Alps? Hear from Katrin Knop, Quality Assurance Specialist, why a career at Lonza in Visp offers a completely new lifestyle for the whole family – relaxed, healthy, close to nature. #thebestofbothworlds www.youtube.com/watch?v=dlYVwOOQEvc
-
Lonza
@LonzaGroup
Are you aware of the possible manufacturing & immunogenicity issues that may be putting your therapeutic candidates at risk? Lonza offers the solution. Meet with our technical experts on the US East and West Coasts, Sep 18th-24th. appliedproteinservices@lonza.com.
-
Lonza
@LonzaGroup
Lonza Houston facility wins 2018 ENR Regional Award for Best Project with @CRB_USA. #celltherapy #viralvectorgenetherapy #nexttogether www.bioportfolio.com/news/article/3711857/Lonza-Houston-C…
-
Lonza
@LonzaGroup
Lonza is looking forward to joining The Swiss Green Economy Symposium on 4 September 2018 in Winterthur (CH) to discuss and exchange successful solutions for sustainable business in Switzerland integrating economy, environment and society. #sges2018
lifefair
@lifefairZH
"Das Swiss Green Economy Symposium 2018 bietet eine gute Gelegenheit, mit vielen Menschen bewährte Ansätze auszutauschen und gemeinsam neue Ideen anzupacken. Nur so lassen sich nachhaltige Gewinne realisieren, die Ökonomie, Umwelt und Gesellschaft integrieren." #sges2018
-
Lonza
@LonzaGroup
Congrats to our CEO Richard Ridinger for being elected as Swiss CEO of the Year 2018 by financial analysis company “Obermatt” (CH). The ranking was published in an article by @sonntagszeitung.
-
Lonza
@LonzaGroup
Next gen biologics require next gen tools for lead selection & expression. Visit Y. Stallwood’s poster presentation during #bpsmt & learn how these tools can help your drug development efforts. Can’t make it to the meeting? Request a poster via: appliedproteinservices@lonza.com
-
Lonza
@LonzaGroup
Check out this article from @GENbio to learn more about the advantages of bioreactor technology and process design in the biopharma industry
Genetic Engineering & Biotechnology News
@GENbio
Bioprocess experts explain how bioreactor technology and process design can achieve greater cell densities, increased titers, larger yields, faster process transfers, and higher quality: www.genengnews.com/magazine/bioreactors-pull-out-some-of-…
-
Lonza
@LonzaGroup
We’re proud to be supporting and inspiring our future generation of scientists through the @bcm_careerdev #jobshadow program #processdevelopment #biologicalmanufacturing
BCM_CareerDev
@bcm_careerdev
Huge thanks to @LonzaGroup Houston for supporting our #jobshadow program and exposing @bcmhouston PhD students to careers in process development & biological manufacturing
-
Lonza
@LonzaGroup
What are the benefits of dry chlorination systems? Find out at the South East Queensland Conference, 9 August, Bargara (QLD), Australia. More info: www.lonza.com/about-lonza/knowledge-center/events/water/S…
-
Lonza
@LonzaGroup
Do you have what it takes to grow as a leader? What counts is your own "initiative" and energy. Find out more in CHRO Fridtjof Helemann’s new blog “You are Crucial.” www.linkedin.com/pulse/you-crucial-fridtjof-helemann/
-
Lonza reposted
Dr. Martina Hestericova
@DrHestericova
How do fireworks work? My new article about the chemistry behind fireworks and the underlying safety concerns. Stay safe and enjoy the #swissnationalday 🎇🇨🇭
#bundesfeiertag #switzerland #fireworks #chemistry #scicomm
medium.com/lonza-pharma-biotech/how-do-fireworks-work-f5e… -
Lonza reposted
Capsugel®
@CapsugelNews
Find out more about formulation selection and in-vitro screening for oral bioavailability enhancement in our #webinar: event.on24.com/eventRegistration/EventLobbyServlet?target…
-
Lonza
@LonzaGroup
NEWS: The NYT reports the revolutionizing potential of non-viral gene editing - A method available with the Lonza 4D-Nucleofector™ System #genetherapy #celltherapy #nexttogether www.nytimes.com/2018/07/11/health/gene-editing-cancer.htm…
-
Lonza
@LonzaGroup
Full-Year 2018 sales outlook was upgraded, and double-digit ROIC Mid-Term Guidance 2022 target was announced #lonzahy18 (www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…)
-
Lonza
@LonzaGroup
#lonzahy18 The analyst-investor conference call is taking place now.
-
Lonza
@LonzaGroup
#lonzahy18 Water Care business gained momentum in May and June with positive outlook from H2 2018 onward www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Growth drivers in Consumer & Resources Protection during #lonzahy18 added to favorable momentum in the division www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Legacy Capsugel businesses, now well integrated into Lonza, exceeded expectations for performance and synergistic potential in #lonzahy18 www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Lonza is holding it’s Half-Year Results Media conference in Basel, Switzerland, now. #lonzahy18
-
Lonza
@LonzaGroup
Outperformance in Pharma & Biotech in H1 2018 in sales, with margins up 270 bps, was combined with strong positive momentum in the newly formed Consumer Health division #lonzahy18 www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Key message from Richard Ridinger, CEO Lonza, on our #lonzahy18 results: www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Lonza Reports Strong Momentum with Organic Growth of 8% Sales and 11% CORE EBITDA in H1 2018 – Double-Digit Organic Sales Growth for Businesses Along the Healthcare Continuum #lonzahy18 news release: www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza reposted
Capsugel®
@CapsugelNews
Come find us at the CRS Annual Meeting and Exposition from tomorrow, July 22nd, to Tuesday, July 24th, in New York City! #crsnyc #nexttogether
-
Lonza
@LonzaGroup
Few days to go till Lonza’s half-year results! Stay tuned on Jul 25. #lonzahy18
-
Lonza
@LonzaGroup
Since 2015 Lonza India has been supporting schools for underprivileged children. On 26 June, Lonza Group General Counsel Andreas Bohrer visited the school to see how our help is changing the lives and learning process of the local students. Learn more here www.lonza.com/about-lonza/global-citizenship/sponsoring/e…
-
Lonza
@LonzaGroup
Exosomics Siena launches its first innovative solutions for cancer diagnostics based on selective isolation of tumor-derived exosome. Lonza to support this innovative company as they develop a platform that will greatly benefit patients. www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Interested in best practices for developing and manufacturing #highlypotent compounds? Join Lonza for a new webinar on this topic. Register here event.on24.com/eventRegistration/EventLobbyServlet?target… #nexttogether
-
Lonza
@LonzaGroup
Don’t miss our webinar, Best Practices for Highly Potent API (HPAPI) Development and Manufacturing, on Wednesday, July 18th at 11AM EDT. Register here event.on24.com/eventRegistration/EventLobbyServlet?target… #nexttogether
-
Lonza
@LonzaGroup
Miranda Delmar on what inspires her work at our newly opened facility in Houston, TX (USA): “It’s the science, it’s the colleagues, it’s the clients and the patients we help them treat.” Find out more www.youtube.com/watch?v=IQa4qJ8xcf0.
-
Lonza
@LonzaGroup
Last Saturday, more than 140 Lonza employees took on the challenge and crossed the finish line on top of the Riffelberg (CH), at 2600m altitude. CONGRATS! Thanks to #gornergratzermattmarathon for the perfect event organization. See you next year at the start line!
-
Lonza
@LonzaGroup
NEWS: #genetherapy using Anc-AAV viral vector licensed by Lonza now one step closer to treating chronic #kidneydisease. Congrats Luk H. Vandenberghe on the publication, proud to be supporting your research. #nexttogether medicine.washu.edu/news/gene-therapy-method-developed-to-…
-
Lonza
@LonzaGroup
Upcoming webinar: "Multiparticulate Formulation Strategies for Pediatric Drugs", 12 July at 11:00AM EDT. Learn how multiparticulate #technology can be used to optimize formulations to improve compliance within patient groups. #nexttogether event.on24.com/eventRegistration/EventLobbyServlet?target…
-
Lonza
@LonzaGroup
Can today’s mammalian expression systems handle the increasingly complex proteins in #drugdiscovery? Lonza’s Andy Racher gives insight in this month’s edition of @PharmTechGroup www.pharmtech.com/view/search-next-gen-expression-systems
-
Lonza
@LonzaGroup
#calyis, or Cambridge Lyphoma Interantional Symposium, takes place on 17-18 July in Cambridge, UK. Lonza will be there too! www.cam.ac.uk
-
Lonza
@LonzaGroup
#issxna2018 at the Palais des congrès de Montréal, Montreal QB, 15-19 July. We are ready! Are you? www.issx.org/events/EventDetails.aspx?id=786763&group=
-
Lonza
@LonzaGroup
Have you already checked out the new website of Lonza Bioscience? bioscience.lonza.com
-
Lonza reposted
Lonza BioResearch Solutions
@LonzaBioRes
@Lonza is pleased to announce the new Bioscience website. The website is designed to support the work of scientists across the drug discovery and pharmaceutical manufacturing spectrum. Click to read full press release: www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Hot off the presses! Today marks the online release of the new book, "Challenges in Protein Product Development", co-edited by #lonzadrugproduct expert, Prof. Dr. Hanns-Christian M. and Pfizer's Dr. Nicholas Warne. Learn more here: link.springer.com/book/10.1007/978-3-319-90603-4
-
Lonza reposted
Capsugel®
@CapsugelNews
How can you simplify and #accelerate the development of a drug product requiring full enteric protection? Find out by watching our #webinar! event.on24.com/eventRegistration/unavailable?®Tag=2384…
-
Lonza
@LonzaGroup
Congratulations to Uwe Gottschalk, Chief Scientific Officer, Lonza Pharma & Biotech, who received the Grand Prix of the French Federation of Biotechnology in recognition of his contributions to the field of industrial biotechnology.
-
Lonza
@LonzaGroup
Looking for a blue sky beyond China? Lonza has solutions for you! We offer a broad spectrum of solutions for customers seeking reliable supplies of key raw materials. To learn more visit: www.lonza.com/chinabluesky
-
Lonza
@LonzaGroup
Lonza in the news: Innovating to meet the demand and address the key challenge in viral vector manufacturing www.evaluate.com/universal/view.aspx?type=Story&id=798570… #nexttogether
-
Lonza
@LonzaGroup
Missed our webinar on next-generation viral vectors for gene therapy last Friday or want to listen to it again? Here is the link to the recording: www.insights.bio/cell-and-gene-therapy-insights/?bio_reso… #nexttogether
-
Lonza
@LonzaGroup
Joining Lonza in Visp is the way to enjoy the best of both worlds. A unique lifestyle in the heart of the Swiss Alps, alongside the opportunity to work with inspiring colleagues in a world-class science and technology facility: youtu.be/D0LRzMu0aws #thebestofbothworlds
-
Lonza reposted
Capsugel®
@CapsugelNews
Visit Capsugel/Lonza at booth E37-38 at the Interphex show in #japan from June 27th-29th! All top leaders from #pharma R&D and manufacturing will be there. www.interphex.jp/hub/en-gb.html
-
Lonza
@LonzaGroup
Congratulations to Simon Ruff from Lonza Visp for winning the UltraCycling World Championship in Austria! Simon keeps in touch with his fans on Facebook "Fanclub Ruff Simon" or his home page www.ruffsimon.com
-
Lonza
@LonzaGroup
Join Lonza Pharma & Biotech in Tokyo, Japan, 27-29 June for the #biopharmaexpo. Visit us at booth #55-34. Learn how we can solve your next challenges in biologics. #lonza #nexttogether #バイオ医薬Expo
-
Lonza
@LonzaGroup
Thank you all for participating in this year’s #hpapi Summit. See you next year!
-
Lonza
@LonzaGroup
The 15th #hepnetsymposium takes place next week, 29 June, in Hannover, Germany. We are excited to participate! www.deutsche-leberstiftung.de/symposium/15.-hepnet-symposium
-
Lonza
@LonzaGroup
Thanks to all our visitors at @intercleanshow Amsterdam! Were you unable to attend and want to learn more about Lonza’s innovative informatics solutions for environmental monitoring for #infectionprevention and control? Then watch this video! www.youtube.com/watch?v=KmVe7G11lOE
-
Lonza
@LonzaGroup
Join the next webinar “Fast-Track Development of an In Vitro 3D Lung/Immune Cell Model Using the Quasi Vivo® System”, on Monday 25 June, 5pm CEST. Info and registration: www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Did you know that the Japanese pharmaceutical market has continued to expand since 2010? And that it is the world’s 2nd largest pharmaceutical market? Visit Lonza at the #interphex show, booth E37-38, and find out how we can help you grow your business!
-
Lonza
@LonzaGroup
How can a fully integrated service offering be beneficial to #drugdevelopers in achieving their goals for delivering a cost-efficient final product? Tomorrow, 21 June, at 9.30am EDT. For more information pharma.lonza.com/events
-
Lonza
@LonzaGroup
Prof. Dr. Hanns-Christian Mahler, Head Drug Product Services at Lonza Pharma & Biotech to present on the first day of #biopharmaexpo on the 27th June, Tokyo, Japan. #lonza #lonzadrugproduct #nexttogether #バイオ医薬Expo
-
Lonza
@LonzaGroup
#chinabluesky supply challenges? Let's solve them now! Visit us at #chemspeceurope, stand C54, to learn more about our offerings for chemical supplies that address the needs of customers affected by the #chinabluesky initiatives. To learn more visit: www.lonza.com/products-services/agro-ingredients/intermed…
-
Lonza reposted
Capsugel®
@CapsugelNews
Tomorrow we kick off at the CPhI in Shanghai - come find us at booth W5C56!
-
Lonza reposted
Capsugel®
@CapsugelNews
Don’t miss our webinar, “Health Aging – Creating Joint Health Products for Addressing the Needs of an Aging Population” June 19 at 2:00pm EST. Register now! www.capsugel.com/webinars/webinar-creating-joint-health-p…
-
Lonza
@LonzaGroup
Join Lonza Pharma & Biotech at #cphichina in Shanghai this week. Meet our experts from Nansha to learn how we can solve your next challenges in small molecules. Visit our booth E2A63, ICSE Zone. #lonza #nexttogeter @CPhIWW
-
Lonza
@LonzaGroup
Lonza’s K.Fallen talks drug development challenges and Lonza solutions with @pharmasalmanac. Read the complete interview here. www.pharmasalmanac.com/articles/addressing-development-ch…
-
Lonza
@LonzaGroup
Next Friday @ISSCR, Lonza Pharma & Biotech and Semma Therapeutics, welcome you for a luncheon co-presentation. Join them to hear a real-life success story in cell & gene therapy manufacturing. www.lonza.com #nexttogether
-
Lonza
@LonzaGroup
#worldcup2018 starts today and we’re launching our #mylonzamyteam campaign on Facebook and Instagram. Our employees feel the #worldcupfever and are ready to support their national teams. Here’s our social media team cheering for Germany and Croatia. Stay tuned!
-
Lonza
@LonzaGroup
Upcoming webinar: Development & manufacture of next-generation viral vectors for gene therapy. Register here www.workcast.com/register?cpak=2566913395479218&referrer=… #nexttogether
-
Lonza
@LonzaGroup
Lonza has the right technologies to solve customers’ challenges as they deal with supply problems caused by the changes in Chinese industry and sustainability requirements as part of the #chinabluesky initiative. Meet us at @ChemspecEurope 2018, stand C54. www.lonza.com/products-services/agro-ingredients/agro-cus…
-
Lonza
@LonzaGroup
Looking for new business opportunities in Asia? #cphi China is your one-stop-shop pharmaceutical platform, a great networking opportunity with China’s market leaders and existing clients. Visit us on 20-22 June at booth W5C56 to discover what Lonza can do for your business!
-
Lonza
@LonzaGroup
Don’t miss the 7th annual #hpapi Summit on 19-21 June in Boston, MA, USA. Participants will be provided with a unified outlook on the latest developments in highly potent compound development. For more information pharma.lonza.com/events
-
Lonza
@LonzaGroup
Today we kicked off our 4th Global #endotoxin Summit in Annapolis, MD & Pickering Beach, DE, USA! To stay up to date, make sure to follow @Lonza_LAL who will be covering the event with lots of updates and interesting news! #2018endosummit
Lonza LAL
@Lonza_LAL
Welcome to our 4th Global #endotoxin Summit! We look forward to meeting our Guest Speakers and attendees. #2018endosummit
-
Lonza
@LonzaGroup
Save the date! #mosaconference2018, 19-20 June, Maastricht, The Netherlands. www.hugedomains.com/domain_profile.cfm?d=mosacell.com
-
Lonza
@LonzaGroup
Lonza hosted a networking event for members of IDCN Basel. M. Glaeser & H.C. Mahler presented insights into our business while Lonza’s HR team provided advice on interview skills. Thanks to IDCN partners @Novartis @Roche @ColgatePalmolive @Bayer @UniBasel @FMIscience @biogen @EY
-
Lonza
@LonzaGroup
Today Lonza is at #achema in Frankfurt, Germany. You can find us in hall 5.00, at booth B54 from 11 to 15 June. Come and learn more about our particle size engineering, jet milling and containment systems! www.lonza.com/about-lonza/knowledge-center/events/pharmab…
-
Lonza
@LonzaGroup
#isscr2018 takes place on 20-23 June at the Melbourne Convention & Exhibition Centre. Come by at booth #51 and meet our experts! www.isscr.org/meetings-events/annual-meetings/isscr-annua…
-
Lonza
@LonzaGroup
Lonza in the news: Partnerships drive innovation and success in ADC manufacturing. #nexttogether www.biopharma-reporter.com/Article/2018/06/08/ADC-Bio-Bio…
-
Lonza
@LonzaGroup
Congratulation to #sutrovax for their successful funding round. We're committed to helping them bring their high-valency conjugate vaccine technology to market and creating a new standard of care for the prevention of #pneumococcal disease. #vaccines
-
Lonza
@LonzaGroup
We’re ready for @UNICEF #cyclingforchildren tomorrow. #lonzateam starts their race to raise money for children at 8.15am. @cransmontana
-
Lonza
@LonzaGroup
Thank you for joining us at @WorldOfWipes
-
Lonza
@LonzaGroup
It’s the last day of #bio2018. There is still time to meet us in booth 56. #nexttogether
-
Lonza reposted
Nonwovens Industry
@NonwovensMag
Is improving patient flow & safety critical for your hospital?
Changing to a low contact time, broad pathogen disinfectant could improve operating room efficiency. #nugen®2M Disinfectant Wipes kills 46 pathogens including Norovirus! Email hygiene@lonza.com for more information -
Lonza
@LonzaGroup
Join us at #awwa Annual Conference & Exposition 2018 on 12-14 June in Las Vegas, NV (USA)! www.lonza.com/about-lonza/knowledge-center/events/water/a…
-
Lonza
@LonzaGroup
Ibex™ is a game changer for the biopharmaceutical industry. Meet our Ibex™ experts at #bio2018 #nexttogether www.youtube.com/watch?v=TElFzdJVwkk
-
Lonza reposted
Capsugel®
@CapsugelNews
Attending The Big Natural on June 6? Don't miss Peter Zambetti's introduction to "Ingredient Innovation – Guidance for Natural Product Manufacturers" at 3:10pm! Get 10% off your registration using the discount code below. #tbn18 www.capsugel.com/events
-
Lonza
@LonzaGroup
Learn about CAR-T 2.0 at the Fierce Biotech Executive Breakfast tomorrow at #bio2018. Register here: pages.questexnetwork.com/CAR-T2.0InnovationNeverStandsSti…
-
Lonza
@LonzaGroup
A packed house during our expert's talk on manufacturing automation for patient-scale cell therapies at the @BioProcessIntl theater @BIOconvention. Meet our experts at booth #375 if you missed it! #nexttogether #bio2018
-
Lonza
@LonzaGroup
The age of manufacturing personalized therapies for patients is here. Visit us for a demonstration of the Octane Cocoon® system. #bio2018 #nexttogether
-
Lonza
@LonzaGroup
New technologies can impact timelines and increase capacity. But how are these technologies developed? Who plays a role in their development? Find out how and who when you attend the roundtable tomorrow at 12:00 in the BioProcess Theater at #bio2018. convention.bio.org
-
Lonza
@LonzaGroup
Join N. Bauer in the BioProcess International Theater at #bio2018 today at 11:00 am. Details here: convention.bio.org/bioprocess-theater/
-
Lonza
@LonzaGroup
Lonza Pharma & Biotech and @Innosieve announced today a distribution agreement for rapid bioburden #testingtechnology that expands Lonza’s offering of #endotoxin products, providing pharmaceutical testing professionals with a wide set of #qc tools. www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Lonza exhibits at the #incosmetics on Jun 13-15 in Seoul, South Korea. See you there! korea.in-cosmetics.com
-
Lonza
@LonzaGroup
Last month, Lonza Ploërmel (France) sponsored the «Broceliande Sport Nature Festival», an event that aims to promote health and sports. The event was a true success and has definitely become one of the yearly highlights in the region.
-
Lonza
@LonzaGroup
Imagine getting a customized solution for your very specific or ambitious task. Over the last 45 years we realized more than 1000 unique products with our customers. Meet us at @ChemspecEurope, Hall 8, Booth C 54. bcove.video/2La0gIX
-
Lonza
@LonzaGroup
CAR-Tregs offer the possibility of expanding #cart technology beyond cancer into #autoimmune disorders and #transplantrejection. @TxCellSA is one of the pioneers and at Lonza Pharma & Biotech we’re proud to be able to put our CAR-T expertise to work. www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Lonza will attend this year's #phss Sterile Products Manufacture Conference 2018 on 7 June in Knutsford, Cheshire (UK). www.lonza.com/about-lonza/knowledge-center/events/pharmab…
-
Lonza
@LonzaGroup
Lonza showcases chemical technologies and #chinabluesky solutions at @ChemspecEurope 2018, Cologne (DE), 20-21 June. Visit us at stand C54! Looking forward to seeing you there! www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
See you at this year’s #pharmatalk on 5-6 June in Berlin, Germany! www.lonza.com/about-lonza/knowledge-center/events/pharmab…
-
Lonza
@LonzaGroup
Join Lonza Pharma & Biotech in Boston, June 5-7, for the @BIOConvention. Visit our booth #563 or attend one of our presentations. Learn how we can help you meet your next biopharmaceutical milestone. Schedule a meeting today: www.lonza.com #bio2018 #nexttogether
-
Lonza
@LonzaGroup
This month, our facility in Suzhou, China, turned 30! Thank you to everybody who, with commitment and engagement, made and will continue to make our company successful. Happy birthday, Lonza Suzhou!
-
Lonza
@LonzaGroup
Read the full article in which @dommattern shares his view on personalized nutrition: www.cvent.com/events/bridge2food-8th-active-performance-s…
Bridge2Food
@Bridge2Food
@dommattern, Head of Business Development for Consumer Health & Nutrition at @LonzaGroup to share his view on personalised nutrition (full story: www.cvent.com/events/bridge2food-8th-active-performance-s…): “I am convinced that there is no one-size-fits-all model in nutrition." #bridge2food #sports #summit #food
-
Lonza
@LonzaGroup
Register now for next Tuesday’s webinar “Tips and Tricks for Efficient Delivery into Primary Cells and Cell Lines” presented by Dr. Elke Lorbach from Lonza Pharma & Biotech. For info and registration: www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Thanks to all our visitors at #interclean2018. It was great to see you there! Were you unable to attend & want to learn more about Lonza’s innovative informatics solutions for environmental monitoring for #infectionprevention? Email us! hygiene@lonza.com @intercleanshow
-
Lonza
@LonzaGroup
Last month, Lonza Greenwood won the Industry Cup at the 26th Annual Golf Classic held by PTC Foundation! Well done, team!
Piedmont Tech
@piedmont_tech
Team from Lonza Wins Industry Cup in PTC Foundation Golf Classic www.ptc.edu/news/team-lonza-wins-industry-cup-in-ptc-foun…
-
Lonza
@LonzaGroup
Join today’s webinar “The Pharma Supply Chain Revolution” at 11am EST. For more info and registration: www.lonza.com/about-lonza/knowledge-center/events/pharmab…
-
Lonza
@LonzaGroup
Our Lonza team is looking forward to seeing you at the #jobvector career day in Frankfurt. Come see us, we have amazing job opportunities! For more info, visit our careers page: lonza.wd3.myworkdayjobs.com/Lonza_Careers #pharma #science #engineering #jobs
@jobvectorDE -
Lonza
@LonzaGroup
88,000 eggs! Did you already know this?
Lonza LAL
@Lonza_LAL
Did you know? Each female #horseshoecrab may lay 88,000 eggs in a nesting season. #2018endosummit
-
Lonza
@LonzaGroup
Isolated and enriched from human liver tissue, Lonza’s hepatic stellate cells, Kupffer cells and liver-derived endothelial cells enable scientists to create more physiologically relevant in vitro models for enhanced liver disease research.
Lonza BioResearch Solutions
@LonzaBioRes
Announced today: Lonza adds hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. Enhance your liver disease research with our complete collection of hepatic cells: www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Visit us at #posidonia2018 to learn about BlueSense™ water care solutions for drinking water sanitation aboard ships. 4-8 June, Athens, Greece. See you there! www.lonza.com/about-lonza/knowledge-center/events/water/p…
-
Lonza
@LonzaGroup
We're present at @FCEPharma, international technology expo and growth driver of the pharmaceutical industry, in São Paulo, Brazil, from 22-24 May, 2018. Capsugel will share a booth with the Lonza Biosciences division & can be found in hall C, at booth C091. See you there!
-
Lonza
@LonzaGroup
Lonza is happy to participate in the #bio International Convention on 4-7 June in Boston, MA (USA). Come see our experts at booth 563! www.lonza.com/about-lonza/knowledge-center/events/custom-…
-
Lonza
@LonzaGroup
#happyfriday Last Sunday some of our Lonza New Plymouth (NZ) employees participated in the annual charity event "Naki Run Amuck". The money raised will go towards Surf Life Saving Taranaki, a non-for-profit charity whose volunteer lifeguards save hundreds of people each year.
-
Lonza
@LonzaGroup
Take a look at the #workinprogress of Lonza’s IBEX™ complex in Visp (CH)!
This media couldn't be displayed. See it on the original post. -
Lonza reposted
New Food Magazine
@NewFoodMag
Visit @LonzaGroup on booth G10 at #vitafoodseurope to get an insight into the speciality ingredients for the food and beverage industry.
-
Lonza
@LonzaGroup
Our experts are here to answer your questions! Visit booth 09.113 in the Healthcare Pavillion.
-
Lonza
@LonzaGroup
We are excited to be at #interclean Amsterdam today! Visit our #lonza team at booth 09.113 in the Healthcare Pavillion to learn more about informatics solutions for environmental monitoring for #infectionprevention and control. @intercleanshow
-
Lonza
@LonzaGroup
Join today’s free webinar “Engineering Culture Platforms to Mimic Liver Diseases” presented by Salman Khetani, Ph.D. Register now and attend at 5pm CEST. www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Panel discussion @Lonzagroup Shanghai symposium. Lively conversation with the audience after the presentations. #nexttogether
-
Lonza
@LonzaGroup
Michael Lieu’ s opening address to @LonzaGroup symposium in Shanghai - "Approaches and tools to maximize success on the journey from research product to clinic" #nexttogether
-
Lonza reposted
Capsugel®
@CapsugelNews
At #vitafoodseurope 2018, Lonza Consumer Health & Nutrition is showcasing its cutting-edge delivery solutions for science-backed ingredients at booth G10 #vfe18
-
Lonza
@LonzaGroup
Lonza Consumer Product Ingredients proudly sponsored the 2018 Formulation Challenge at in-cosmetics global in Amsterdam. Congrats to the winner Naturalps for its Eye Rescue formula, utilising our broad-spectrum & COSMOS-certified GeogardECT as preservative www.in-cosmetics.com/about-the-show/show-features/seminar…
-
Lonza
@LonzaGroup
Are you interested in science & technology? We offer several exciting Technologist opportunities at Lonza Slough. To learn more watch this video www.youtube.com/watch?v=c-is9Jjv02Q and apply today: lonza.wd3.myworkdayjobs.com/en-US/Lonza_Careers/job/UK---…
-
Lonza
@LonzaGroup
We want to see you at Suppliers' Day at the Javits Convention Center in NYC, 15-16 May! Come visit us at booth #1011 to learn about our offerings for skin and scalp health. Stop by our booth and try Lonza’s scalp health analyzer. #suppliersday2018
-
Lonza
@LonzaGroup
Save the date: #biotalkus is scheduled for May 23-24 in Boston, MA. We’ll be there too. Come by to see us!
-
Lonza
@LonzaGroup
Pawel Gruszczynski, Territory Sales Manager at Lonza Pharma & Biotech, will speak on “Modern Quality Control – Capsules in Sigma Series standard” at this year's Spring Conference on Pharmaceuticals, in Gniew Poland, 17-18 May. www.capsugel.com/events/spring-conference-on-pharmaceutic…
-
Lonza
@LonzaGroup
Want to learn about innovative informatics solutions for environmental monitoring for #infectionprevention and control? Don’t forget to drop by the #lonza booth 09.113 in the Healthcare Pavillion at #interclean Amsterdam, 15-18 May 2018 www.lonza.com/interclean2018 @intercleanshow
-
Lonza
@LonzaGroup
#actc2018 takes place on 21-23 May at Cardiff University. Lonza will be there! actc2018.com
-
Lonza
@LonzaGroup
Our thought leaders in Cell and Gene Therapy will play an active role @ASGCT in Chicago next week. Join and discuss with them what matters most to you! #nexttogether www.lonza.com
-
Lonza
@LonzaGroup
Join our free webinar “Tips and Tricks for Efficient Delivery into Primary Cells and Cell Lines” on May 29! For more info and registration: www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Join us on 24 May at 11am (EST) for the webinar “The Pharma Supply Chain Revolution”. You will learn how VMI with the help of EDI is the foundation for supply chain collaboration and success. For info and registration: event.on24.com/eventRegistration/EventLobbyServlet?target…
-
Lonza
@LonzaGroup
Europe's finest life sciences conference #knowledgeforgrowh takes place in Ghent, Belgium on May 17. Don’t miss it! www.knowledgeforgrowth.be
-
Lonza
@LonzaGroup
Save the date! Lonza will be exhibiting in the Healthcare Pavillion at #interclean Amsterdam from 15-18 May 2018. Visit us at booth 09.113 to learn about Lonza’s informatics solutions for environmental monitoring in infection prevention: www.lonza.com/interclean2018 @intercleanshow
-
Lonza
@LonzaGroup
Last Friday Lonza’s Annual General Meeting took place. Let’s welcome our newly elected members of the Board of Directors: Angelica Kohlmann and Olivier Verscheure!
-
Lonza reposted
Proteon Therapeutics
@ProteonTx
We recently had the chance to say "thank you" to the project team at @LonzaGroup for 10 years of service. Learn more about our recent accomplishments: ir.proteontherapeutics.com/news-releases/news-release-det…
-
Lonza
@LonzaGroup
Lonza is participating in this year’s Cycling for Children event in Cans-Montana (CH), organized by UNICEF. The aim is to show commitment through creative fundraising and sporting performance to help children in need. Join now: www.unicef.ch/en/cycling-for-children/participate/register
-
Lonza
@LonzaGroup
«In Trust We Trust!» Read the latest article by our CHRO, Fridtjof Helemann, and find out what the single most important factor in high performing teams is. www.linkedin.com/pulse/trust-we-fridtjof-helemann/
-
Lonza
@LonzaGroup
Latest innovations and great networking opportunities in NYC at #suppliersday2018 on May 15-16. We are going! What about you? nyscc.org/suppliers-day/
-
Lonza
@LonzaGroup
Join this year’s @WHO "SAVE LIVES: Clean Your Hands" 5 May campaign to prevent #sepsis in health care. Learn more about the campaign and register at www.who.int/campaigns/save-lives-clean-your-hands/sign-up… #handhygiene #infectionprevention @GLOBAL_POPS @DidierPittet
-
Lonza
@LonzaGroup
#2018lonzaq1 Announcing state-of-the-art technological advancements and expansion of Lonza's Portsmouth, NH (USA) site www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
See you next year at AGM 2019 on 18 April 2019!
-
Lonza
@LonzaGroup
Start of production in the world’s largest dedicated cell-and-gene-therapy manufacturing facility in Pearland, Greater Houston, TX (USA) adds to global technology footprint and innovative offerings #2018lonzaq1 #nexttogether
-
Lonza
@LonzaGroup
Thank you, Rolf Soiron, for 13 years at Lonza!
-
Lonza
@LonzaGroup
CEO Richard Ridinger giving his speech to AGM 2018 now
-
Lonza
@LonzaGroup
#2018lonzaq1 Ongoing progress to achieve a positive half-year result 2018 www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Rolf Soiron opens #lonza’s Annual General Meeting 2018 with a speech and welcomes students from High School Oberwil
-
Lonza
@LonzaGroup
The former Capsugel business, now part of Lonza Pharma & Biotech and Lonza Consumer Health, performed well in Q1; integration continues as planned #2018lonzaq1 www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Everything is ready for #lonza‘s AGM 2018! Doors are open for our shareholders and guests.
-
Lonza
@LonzaGroup
Continued strong demand for pharma offerings in Clinical Development and Manufacturing, Commercial Manufacturing and Consumer Health #2018lonzaq1 www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Key message from CEO Richard Ridinger on #2018lonzaq1. Read the full news release under www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
#2018lonzaq1 Lonza Reports Positive Start to 2018 with Businesses Along the Healthcare Continuum as Growth Drivers. www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
World #handhygiene Day is on 5 May 2018. Did you know practicing the 5 Moments of #handhygiene can help to prevent infections including #sepsis. Learn more www.who.int/campaigns/save-lives-clean-your-hands/sign-up… #handhygiene #infectionprevention @GLOBAL_POPS
-
Lonza
@LonzaGroup
Join our free webinar “Engineering Culture Platforms to Mimic Liver Diseases” on May 16 for an overview of complex models related to liver disease research! For more info and registration click here: www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
We’re excited to participate in the #intercleanamsterdam 2018 on 15-18 May! Come see us at booth 09.113! www.lonza.com/about-lonza/knowledge-center/events/consume…
-
Lonza reposted
Capsugel®
@CapsugelNews
Attending #vitafoodseurope 2018? Visit Lonza Consumer Health & Nutrition on booth G10 to explore the latest ingredients, delivery systems and finished product formulations for the nutraceuticals industry #vfe18
-
Lonza
@LonzaGroup
Lonza Water Care celebrated 1-year anniversary of the #sanitationforafrica project, which has so far treated 2323 pit latrines, aiming at 3000 by the end of June 2018. The milestone was celebrated at ABATEC primary school in the Wakiso district of Uganda.
-
Lonza
@LonzaGroup
As a participant of the ‘Private Organizations for Patient Safety’ (POPS) group for Hand Hygiene, Lonza will be supporting the annual "SAVE LIVES: Clean Your Hands" campaign. Click for info: www.who.int/infection-prevention/campaigns/clean-hands/5m…
#handhygiene #infectionprevention @GLOBAL_POPS @DidierPittet -
Lonza
@LonzaGroup
The 11th Dutch Stem Cell Meeting takes place on 4 May in Utrecht, Netherlands. We are excited! Are you? dsscr.nl
-
Lonza
@LonzaGroup
John Harris CEO of @OBN_UK overviews @LonzaGroup's viral gene therapy revolution symposium in Oxford www.linkedin.com/top-content/career/
-
Lonza
@LonzaGroup
One week to go to the Annual General Meeting!
-
Lonza
@LonzaGroup
Thanks to @OBN_UK for helping us arrange the symposium, and the great insights and discussion with keynote speakers.
-
Lonza
@LonzaGroup
We are excited to participate in #immunology2018 on May 4-8 in Austin, TX, US. Are you excited too? Come see us at booth # 635. www.immunology2018.org
-
Lonza reposted
LabTube
@LabTube
LabTube Meets Robert Porzio @ SLAS 2018 @LonzaGroup @Tech_Networks www.technologynetworks.com/tn/videos?lrn=true
-
Lonza
@LonzaGroup
Sarah Holland, Global Head of Licensing, Lonza Pharma & Biotech, on the Perfect Pitch panel #biotrinity2018. To learn more visit: pharma.lonza.com/cell-and-gene-therapy #nexttogether
-
Lonza
@LonzaGroup
Let’s talk about how our biopharmaceutical development services will help to position your therapeutic candidates for success. Meet us next week at #pegsboston, booth 426. Learn more about the meeting here: www.pegsummit.com #nexttogether
-
Lonza
@LonzaGroup
"Cell & Gene therapy Cost v Rarity Panel" led by @ryanscanlon, Head of Licensing Commercial Development #biotrinity2018. Find out more about Lonza's cell and gene therapy: pharma.lonza.com/cell-and-gene-therapy #nexttogether
-
Lonza
@LonzaGroup
The Viral Gene Therapy Revolution symposium in association with @OBN_UK starts tomorrow in Oxford www.eventbrite.co.uk/e/lonza-pharma-biotech-symposium-the…. Looking forward to the insights and discussion with keynote speakers. #genetherapy #aav #biotrinity18
-
Lonza
@LonzaGroup
We‘re at the Polymesse in Zürich today, at @ETH main building. Stop by our Lonza booth to learn more about your career opportunities at Lonza Visp! See you there!
-
Lonza
@LonzaGroup
We’re driving the next-generation of #biomanufacturing with our partner @Synpromics and support from @Innovate UK. Lonza Pharma & Biotech will be testing and validating their inducible promoter in our GS expression system®. To read more visit www.sciadnewswire.com/news/446/synpromics-awarded-innovat…
-
Lonza
@LonzaGroup
At this year’s @biotrinity, Lonza Pharma & Biotech will chair tomorrow’s “Cell & Gene Therapy – Cost v Rarity panel discussion” at 11.50am (GMT) and participate in the “Perfect Pitch Session” at 3pm (GMT). Looking forward to seeing you there! biouk.glueup.com/event/biotrinity-2027-184799/
-
Lonza reposted
MEDiSTRAVA, an Inizio Company
@MEDiSTRAVA_
With this year's @biotrinity well underway, @ScripMikeWard of @PharmaScrip speaks to @LonzaGroup's Ryan Scanlon about what makes #biotrinity2018 Europe's leading biopartnering and investment conference #pharma #biotech #london
-
Lonza reposted
MEDiSTRAVA, an Inizio Company
@MEDiSTRAVA_
Ryan Scanlon, Head of Viral Gene Therapy at @LonzaGroup speaks to @ScripMikeWard @PharmaScrip about solving the manufacturing challenges in cell and gene therapy at @biotrinity #biotrinity2018
-
Lonza reposted
Capsugel®
@CapsugelNews
Join us in booth #605 at CPhI North America this week. @CPhIWW #cphinorthamerica
-
Lonza
@LonzaGroup
Our Lonza Greenwood employees participated in Dancing with the Greenwood Stars and won the People’s Choice Award as well as the Best Dance Group Award. Well done, team!
-
Lonza
@LonzaGroup
Have you registered for tomorrow’s free webinar ‘Integrating Devices into Quality Systems’? Click here: www.lonza.com/about-lonza/knowledge-center/events/pharmab… ow.ly/d/7ypV
-
Lonza
@LonzaGroup
Lonza Greenwood raised $104,491.30 at the annual fundraising campaign for @UnitedWay, a fundraising organization that fights for the health, education, and financial stability of every person in every community.
-
Lonza
@LonzaGroup
Our Lonza Porriño employees have successfully run the XIX Half Marathon Vig-Bay, a popular marathon race of the region with ca. 5000 runners. The course links Vigo with Bayona, which is also the origin of the marathon’s name. Good job, guys!
-
Lonza
@LonzaGroup
We are excited to participate in #vitafoodseurope2018, Geneva (CH), on 15-17 May. Visit us at booth G10 to learn more about our cutting-edge delivery solutions for science-backed ingredients. www.capsugel.com/news/lonza-consumer-health-and-nutrition…
-
Lonza
@LonzaGroup
Last day at #incosglobal! Come see us at booth E80! For more info visit www.cosmeticsbusiness.com/lonza-showcases-new-bioactive-i…
-
Lonza
@LonzaGroup
Lonza Consumer Health and nutrition will present cutting-edge delivery solutions for science-backed ingredients at #vitafoodseurope2018. Click here to learn more: www.capsugel.com/news/lonza-consumer-health-and-nutrition…
-
Lonza
@LonzaGroup
We're at #cphijapan. Visit us at booth #u-09 ICSE to find out more about our expanded small molecules service offering. See you there! #nexttogether www.cphi.com/japan/
-
Lonza
@LonzaGroup
Visit us at #incosglobal (E80) to try on our new two-part “Urban Shield” prototype skin-defense system. Comprising a silky-feeling cleansing milk followed by a charcoal mask, the system is designed to provide superior skin care support from aggressive environmental pollutants.
-
Lonza
@LonzaGroup
Don’t miss Lonza’s Eduardo Jule’s technical presentation “Development and manufacturing of highly potent drug products” during #cphijapan 2018 on Thursday. #lonza #nexttogether www.cphi.com/japan/
-
Lonza
@LonzaGroup
Lonza to introduce new #scalp #care portfolio at #incosglobal. Healthy hair begins with a healthy scalp! Visit stand E80 to find out more! www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Cell & gene therapy explained in 90 seconds! Ever wondered what cell and gene therapy is and how it works? Watch this short video animation to find out more and discover Lonza’s role in this emerging field. www.youtube.com/watch?v=IQa4qJ8xcf0
-
Lonza
@LonzaGroup
Come see us at stand E80! #incosglobal
-
Lonza
@LonzaGroup
Visit our #lonza Consumer Product Ingredients team at #incosglobal 2018, 17-19 April, Amsterdam (NL). We're looking forward to seeing you at stand #e80!
-
Lonza reposted
Lonza BioResearch Solutions
@LonzaBioRes
Our Lonza Team welcomes you to Booth # 707 at AACR this week. Let us help you plug in the critical missing pieces in your cancer studies.Learn how our products are helping cancer researchers overcome the challenges of cell culture optimization. www.lonza.com/aacr
-
Lonza
@LonzaGroup
Recently, Lonza Water Care representatives volunteered on the island of Curaçao (Venezuela), at a children’s shelter in need of improvements. Read more here: www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
This year Lonza is participating in the Portsmouth #commutesmart B2B Challenge, which aims at encouraging commuters to use sustainable modes of transportation. To learn more: commutesmartseacoast.org/challenge/b2b-challenge-2018
-
Lonza
@LonzaGroup
Congrats to @LonzaWoodPro!
Bond Timber
@BondTimber
Last night Shaun picked up the award we WON for Excellence in Marketing at the WPA Awards!!
#winnerwinner #awardwinning @woodprotection @LonzaGroup -
Lonza
@LonzaGroup
Come and join the Lonza Personal Care Team at In-Cosmetics in Amesterdam, Apr 17-19 stand E80 - We look forward to seeing you! www.in-cosmetics.com/visit
-
Lonza
@LonzaGroup
Join Lonza’s Webinar “Achieve Enteric Protection without The Coating Step”, presented by Matt Richardson and Christian Klein today at 3pm (GMT). For more info and registration visit: www.pmi-live.com/events/webinar/Pharma/Achieve_Enteric_Pr…
-
Lonza
@LonzaGroup
Join Lonza’s free webinar “Integrating Devices into Quality Systems” on 24 April. For more info and registration click here: www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
CPhI Japan's coming up next week. Visit Lonza Pharma&Biotech at #cphijapan, booth #u-09 ICSE where we're presenting our expanded small molecules service offering, which includes drug substances, drug product intermediates and drug products. #nexttogether www.cphi.com/japan/
-
Lonza
@LonzaGroup
Yesterday Lonza inaugurated the world’s largest dedicated cell and gene therapy facility in Houston. Watch the video! #lonzahoustonlaunch #nexttogether #lonza www.youtube.com/watch?v=_8EvxNTtYbE
-
Lonza
@LonzaGroup
Scott Brown will be presenting at 12:30 “A New Approach for Preservation of Coatings Formulations.” Don’t miss it! #acs2018
-
Lonza
@LonzaGroup
Don’t miss #lonza’s Scott Brown’s technical presentation “A New Approach for Preservation of Coatings Formulations” during #acs2018 on Wednesday.
-
Lonza
@LonzaGroup
The sound of Swiss horns echoed during the #lonza flag raising ceremony, concluding the Grand Opening of our new, state-of-the-art Lonza Houston cell and gene facility today. #nexttogether #lpb #lonzahoustonlaunch
-
Lonza
@LonzaGroup
Our CEO, R. Ridinger, our Pharma & Biotech COO, M. Funk, the 29th district of Texas state representative, E. Thompson, the Pearland city mayor, T. Reid & site head, R. Jimenez cut the red ribbon inaugurating the world’s largest dedicated cell & gene therapy manufacturing facility
-
Lonza reposted
BioHouston
@BioHouston
We are proud to be here for the grand opening of the @LonzaGroup facility in Pearland. This facility is the largest cell and gene therapy center in the world. Certainly a milestone moment for our growing Houston ecosystem.
-
Lonza reposted
Pearland EDC
@PearlandEDC
“Our industry is taking a big step forward today as we dedicate the largest gene and cell therapy facility in the world.” - Richard Ridinger @LonzaGroup CEO
-
Lonza reposted
Genetic Engineering & Biotechnology News
@GENbio
. @LonzaGroup Opens Cell and #genetherapy Facility in Pearland, TX: www.genengnews.com/topics/drug-discovery/lonza-opens-cell…
-
Lonza reposted
Deborah Mansfield
@dotconnecter
Mark Funk CEO, Pharma & Biotech @LonzaGroup championing the potential of cell & genetherapy against diseases like cancer - a shift for therapy
-
Lonza reposted
Clay Pearson
@jayhawkmi
@LonzaGroup new 300k sq door ‘House of Hope’ will save lives w advanced custom design gene therapies w partners like @bluebirdbio Amazing people here as part of @PearlandEDC @GHPartnership @TMCInnovation ecosystem.
-
Lonza reposted
Pearland EDC
@PearlandEDC
“I don’t consider this a building, I consider it a house of hope.” -Nick Leschly, CEO of bluebird bio, as he, Brad Zakes, Founder of Ethan Zakes Foundation & Andreas Weiler, PhD, SVP of Emerging Technologies at Lonza share the story of Ethan at @LonzaGroup grand opening.
-
Lonza
@LonzaGroup
Visit Lonza at #acs2018 to learn about MIT-free preservation and our new product Proxel Spektra™ Preservative.
-
Lonza
@LonzaGroup
Imagine having up to 9,000 global cosmetic manufacturers under the same roof. #incosmetics makes it possible! Amsterdam, Apr 17-19. See you there! www.in-cosmetics.com
-
Lonza
@LonzaGroup
Exhibits open tomorrow at the American Coatings Show #acs2018! Stop by and see us at booth #1055
-
Lonza
@LonzaGroup
One week to go to the Oxford Immunology Symposium in Oxford, UK. Meet us on 16-17 April! www.dtc.ox.ac.uk
-
Lonza
@LonzaGroup
Save the date! The #britishmicrocirculationsociety meeting takes place on Apr 16-17 in Nottingham, UK. Are you coming too? www.microcirculation.org.uk
-
Lonza
@LonzaGroup
Lonza will be exhibiting at the #aacr2018 in Chicago, on 14-18 April. Come Meet Us in Booth #707! www.lonza.com/about-lonza/knowledge-center/events/biorese…
-
Lonza
@LonzaGroup
Lonza to introduce a new addition to the Proxel® range of preservatives at the #acs18, 10-12 April 2018, Indianapolis, IN (USA). Looking forward to seeing you there! To learn more visit: www.lonza.com/about-lonza/media-center/news/Tensid/2018-0…
-
Lonza
@LonzaGroup
Read #globalbusinessreports latest US Biopharmaceuticals Connect Series: Interview with Joseph Colleluori, Senior Vice President Corporate Development, Lonza Pharma & Biotech. www.gbreports.com/interview/joseph-colleluori
-
Lonza
@LonzaGroup
Apply today for a job at Lonza! Check out our careers page under lonza.wd3.myworkdayjobs.com/Lonza_Careers to discover current opportunities!
Labiotech.eu
@Labiotech_eu
Need a new job? These #biotech companies want you! @LonzaGroup @Regeneron @TxCellSA @diasoringroup goo.gl/EeGiUZ
-
Lonza
@LonzaGroup
Sarah Holland, Lonza Pharma&Biotech’s global head of licensing, said: “The GS Expression System and the CHOK1SV cell line are proven key components of an industry-leading mammalian expression platform."
-
Lonza
@LonzaGroup
H.C. Mahler, #lonzadrugproduct Services, on developments in pre-filled syringes to be discussed at @PDAonline Conf. www.youtube.com/watch?v=Tgi1-LkA2KQ
-
Lonza
@LonzaGroup
Did you know? Salt pools require the same maintenance as chlorine pools. #saltorchlorine www.saltorchlorine.org






















































































































































































































































































































































































































































































































































